GRK7
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A4FU28 | S138 | Sugiyama | CTAGE9 | EKAAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKS |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A6NMY6 | S127 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| A6NMY6 | T123 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| O00505 | S60 | Sugiyama | KPNA3 QIP2 | KRDEHLLKKRNVPQEEsLEDsDVDADFKAQNVTLEAILQNA |
| O14974 | S912 | Sugiyama | PPP1R12A MBS MYPT1 | TssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTDF |
| O14980 | S1031 | Sugiyama | XPO1 CRM1 | FKEHLRDFLVQIKEFAGEDtsDLFLEEREIALRQADEEKHK |
| O14980 | T1030 | Sugiyama | XPO1 CRM1 | AFKEHLRDFLVQIKEFAGEDtsDLFLEEREIALRQADEEKH |
| O43719 | S600 | Sugiyama | HTATSF1 | EKELHENVLDKELEENDsENsEFEDDGsEKVLDEEGsEREF |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O60610 | S542 | Sugiyama | DIAPH1 DIAP1 | ALHSEKQQIATEKQDLEAEVsQLtGEVAKLTKELEDAKKEM |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75822 | S127 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLtPEEQLADKLRLKKLQEEsDLELAKEtFGVNNAVyGIDA |
| O94888 | S288 | Sugiyama | UBXN7 KIAA0794 UBXD7 | sssPPKKCARsEsLIDAsEDsQLEAAIRASLQETHFDstQT |
| O95155 | S118 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | QsLsRsQsMDIDGVSCEKsMsQVDVDsGIENMEVDENDRRE |
| O95155 | S124 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | QsMDIDGVSCEKsMsQVDVDsGIENMEVDENDRREKRsLsD |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| P00558 | S415 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGGAsLELLEGKVLPGVDALsNI__________________ |
| P02533 | S321 | Sugiyama | KRT14 | DAEEWFFTKTEELNREVATNsELVQSGKSEISELRRTMQNL |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | S434 | Sugiyama | ALPP PLAP | LYGNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDEETH |
| P05198 | T284 | Sugiyama | EIF2S1 EIF2A | EKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVDGDD |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S304 | Sugiyama | RPLP0 | AttAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07237 | T85 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KAAGKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFF |
| P07355 | S127 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | T123 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| P07858 | S323 | Sugiyama | CTSB CPSB | DWGDNGFFKILRGQDHCGIEsEVVAGIPRTDQYWEKI____ |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P08195 | S403 | Sugiyama | SLC3A2 MDU1 | SDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYL |
| P08195 | T106 | Sugiyama | SLC3A2 MDU1 | SDPPALASKNAEVTGTMsQDtEVDMKEVELNELEPEKQPMN |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08758 | S136 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | sRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRMLVVL |
| P0CAP2 | S144 | Sugiyama | POLR2M GRINL1A | SQTSQNQGLGRPTLEGDEETsEVEYTVNKGPASSNRDRVPP |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG41 | S138 | Sugiyama | CTAGE8 | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P10696 | S431 | Sugiyama | ALPG ALPPL ALPPL2 | LYGNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDGETH |
| P10809 | S383 | Sugiyama | HSPD1 HSP60 | DKAQIEKRIQEIIEQLDVttsEyEKEKLNERLAKLsDGVAV |
| P10809 | T382 | Sugiyama | HSPD1 HSP60 | GDKAQIEKRIQEIIEQLDVttsEyEKEKLNERLAKLsDGVA |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S578 | Sugiyama | EEF2 EF2 | LKDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNK |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13797 | S110 | Sugiyama | PLS3 | AKTFRKAINRKEGICALGGTsELssEGtQHsysEEEKyAFV |
| P13797 | S120 | Sugiyama | PLS3 | KEGICALGGTsELssEGtQHsysEEEKyAFVNWINKALEND |
| P13797 | S122 | Sugiyama | PLS3 | GICALGGTsELssEGtQHsysEEEKyAFVNWINKALENDPD |
| P13798 | S185 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | VAEKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQ |
| P13861 | S80 | Sugiyama | PRKAR2A PKR2 PRKAR2 | GHPPPEPGPDRVADAKGDsEsEEDEDLEVPVPsRFNRRVsV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S306 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | TETVEEPMEEEEAAKEEKEEsDDEAAVEEEEEEKKPKTKKV |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P16333 | S96 | Sugiyama | NCK1 NCK | GIGKVKRKPsVPDsAsPADDsFVDPGERLyDLNMPAyVKFN |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17096 | S103 | Sugiyama | HMGA1 HMGIY | PRGRPKKLEKEEEEGIsQEssEEEQ________________ |
| P17812 | S578 | Sugiyama | CTPS1 CTPS | GCRLsPRDtysDRsGsssPDsEItELKFPsINHD_______ |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P25205 | S711 | Sugiyama | MCM3 | RRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADsQEt |
| P25705 | S53 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | ARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETGR |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25788 | S250 | Sugiyama | PSMA3 HC8 PSC8 | KDIREEAEKyAKEsLKEEDEsDDDNM_______________ |
| P25788 | Y239 | Sugiyama | PSMA3 HC8 PSC8 | ELTNGRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM____ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P27797 | S189 | Sugiyama | CALR CRTC | THLytLIVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIK |
| P27816 | S643 | Sugiyama | MAP4 | IsPEtVTGtGKKCsLPAEEDsVLEKLGERKPCNsQPSELSS |
| P27824 | S554 | Sugiyama | CANX | EKDKGDEEEEGEEKLEEKQKsDAEEDGGtVsQEEEDRKPKA |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34932 | S414 | Sugiyama | HSPA4 APG2 HSPH2 | ITDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTF |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P41227 | S213 | Sugiyama | NAA10 ARD1 ARD1A TE2 | ACREEKGLAAEDsGGDsKDLsEVsEtTEstDVKDssEAsDs |
| P41227 | S216 | Sugiyama | NAA10 ARD1 ARD1A TE2 | EEKGLAAEDsGGDsKDLsEVsEtTEstDVKDssEAsDsAs_ |
| P43003 | S512 | Sugiyama | SLC1A3 EAAT1 GLAST GLAST1 | GIVEHLSRHELKNRDVEMGNsVIEENEMKKPyQLIAQDNET |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P47712 | S731 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | AMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA__ |
| P47756 | S204 | Sugiyama | CAPZB | sGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKI |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49321 | S127 | Sugiyama | NASP | GNALEGVHVEEEEGEKtEDEsLVENNDNIDEEAREELREQV |
| P49321 | S432 | Sugiyama | NASP | EKVRAKLVPsQEEtKLsVEEsEAAGDGVDTKVAQGAtEKsP |
| P49321 | S497 | Sugiyama | NASP | tEGsEEDDKENDKtEEMPNDsVLENKsLQENEEEEIGNLEL |
| P49327 | S2198 | Sugiyama | FASN FAS | EVRQLTLRKLQELSSKADEAsELACPtPKEDGLAQQQtQLN |
| P49588 | S188 | Sugiyama | AARS1 AARS | PGNMKDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDD |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50502 | S79 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | KPDSKKVEEDLKADEPssEEsDLEIDKEGVIEPDTDAPQEM |
| P50851 | S993 | Sugiyama | LRBA BGL CDC4L LBA | QPDtKDsPVCPHFttNGNENssIEKTSsLEsASNIELQTTN |
| P50897 | S262 | Sugiyama | PPT1 CLN1 PPT | EWFGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVF |
| P51580 | S14 | Sugiyama | TPMT | _______MDGTRTSLDIEEysDtEVQKNQVLTLEEWQDKWV |
| P52789 | S889 | Sugiyama | HK2 | PHFAKVMHETVKDLAPKCDVsFLQsEDGSGKGAALITAVAC |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S17 | Sugiyama | SUB1 PC4 RPO2TC1 | ____MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPV |
| P53999 | S19 | Sugiyama | SUB1 PC4 RPO2TC1 | __MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPVKK |
| P54578 | S492 | Sugiyama | USP14 TGT | WHIAYVLLYGPRRVEIMEEEsEQ__________________ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P55060 | T341 | Sugiyama | CSE1L CAS XPO2 | LASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEA |
| P56385 | S66 | Sugiyama | ATP5ME ATP5I ATP5K | EEKKKQDELKRIARELAEDDsILK_________________ |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60900 | S177 | Sugiyama | PSMA6 PROS27 | AGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTVET |
| P60900 | T176 | Sugiyama | PSMA6 PROS27 | PAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTVE |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63146 | S148 | Sugiyama | UBE2B RAD6B UBCH1 | QLYQENKREYEKRVsAIVEQsWNDS________________ |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q04695 | S290 | Sugiyama | KRT17 | DAEDWFFsKTEELNREVATNsELVQSGKSEISELRRTMQAL |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q08211 | S125 | Sugiyama | DHX9 DDX9 LKP NDH2 | LPttMGGPLPPHLALKAENNsEVGAsGyGVPGPTWDRGANL |
| Q13144 | S527 | Sugiyama | EIF2B5 EIF2BE | EEELQQNLWGLKINMEEEsEsESEQSMDsEEPDsRGGsPQM |
| Q13263 | S479 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERLDLDLtA |
| Q13371 | S296 | Sugiyama | PDCL PHLOP1 PhLP1 | EKEVLVLTSVRNsAtCHsEDsDLEID_______________ |
| Q13428 | S85 | Sugiyama | TCOF1 | AEEDAALQAKKTRVsDPIstsEssEEEEEAEAETAKAtPRL |
| Q13428 | S87 | Sugiyama | TCOF1 | EDAALQAKKTRVsDPIstsEssEEEEEAEAETAKAtPRLAs |
| Q13428 | S88 | Sugiyama | TCOF1 | DAALQAKKTRVsDPIstsEssEEEEEAEAETAKAtPRLAst |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13547 | S421 | Sugiyama | HDAC1 RPD3L1 | PDKRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAK |
| Q13547 | S423 | Sugiyama | HDAC1 RPD3L1 | KRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAKRV |
| Q14151 | S207 | Sugiyama | SAFB2 KIAA0138 | FKNtLEtssLNFKVtPDIEEsLLEPENEKILDILGEtCKsE |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14203 | S417 | Sugiyama | DCTN1 | KKNQELEVVRQQRERLQEELsQAEstIDELKEQVDAALGAE |
| Q14203 | T422 | Sugiyama | DCTN1 | LEVVRQQRERLQEELsQAEstIDELKEQVDAALGAEEMVEM |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14980 | S863 | Sugiyama | NUMA1 NMP22 NUMA | EKARQELQEAKEKVAGIEsHsELQISRQQNELAELHANLAR |
| Q14C86 | S576 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | HGKPDKTLRFSLCsDNLEGIsEGPSNRSNSVSSLDLEGESV |
| Q15003 | S733 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | ACLLHLANEKNLKLEGtEDLsDVLVRQGD____________ |
| Q15084 | S428 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | EREPWDGRDGELPVEDDIDLsDVELDDLGKDEL________ |
| Q15185 | S118 | Sugiyama | PTGES3 P23 TEBP | WLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGDEDVDL |
| Q16204 | S327 | Sugiyama | CCDC6 D10S170 TST1 | KLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQGLRP |
| Q16625 | S471 | EPSD|PSP | OCLN | DEINKELSRLDKELDDYREEsEEyMAAADEYNRLKQVKGsA |
| Q16637 | S31 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | GVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDKAVAsFK |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q6P996 | S779 | Sugiyama | PDXDC1 KIAA0251 | QHtDQtEAFQKGVPHPEDDHsQVEGPEsLR___________ |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7Z3K6 | S53 | Sugiyama | MIER3 | YDDERTLEEEEMMDEGKNFssEIEDLEKEGTMPLEDLLAFY |
| Q86UF2 | S138 | Sugiyama | CTAGE6 CTAGE6P | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q8IX94 | S138 | Sugiyama | CTAGE4 | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBS9 | S292 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSEAPV |
| Q8NE71 | S595 | Sugiyama | ABCF1 ABC50 | TKEALTRKQQKCRRKNQDEEsQEAPELLKRPKEYTVRFTFP |
| Q8NHW5 | S304 | Sugiyama | RPLP0P6 | DTTAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WTQ7 | S36 | Sugiyama | GRK7 GPRK7 | YLQARKPsDCDSKELQRRRRsLALPGLQGCAELRQKLSLNF |
| Q8WTQ7 | S490 | SIGNOR|Sugiyama | GRK7 GPRK7 | PFVPDPSVVYAKDIAEIDDFsEVRGVEFDDKDKQFFKNFAT |
| Q8WVC0 | S66 | Sugiyama | LEO1 RDL | DQDERGDSGQPSNKELFGDDsEDEGAsHHsGSDNHSERSDN |
| Q8WVJ2 | S153 | Sugiyama | NUDCD2 | GFDFsGAEIsGNytKGGPDFsNLEK________________ |
| Q92769 | S422 | Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q92769 | S424 | Sugiyama | HDAC2 | KRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGAKK |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96K76 | S903 | Sugiyama | USP47 | LSLQQQQDGDNGDssKstEtsDFENIEsPLNERDsSAsVDN |
| Q96S66 | S59 | Sugiyama | CLCC1 KIAA0761 MCLC | MRKSQAKYGISGEKDVSPDLsCADEIsECyHKLDSLTYKID |
| Q96S66 | Y68 | Sugiyama | CLCC1 KIAA0761 MCLC | ISGEKDVSPDLsCADEIsECyHKLDSLTYKIDECEKKKRED |
| Q96SB4 | S334 | Sugiyama | SRPK1 | ERPLKENPPNKMtQEKLEEsstIGQDQtLMERDTEGGAAEI |
| Q96SB4 | T341 | Sugiyama | SRPK1 | PPNKMtQEKLEEsstIGQDQtLMERDTEGGAAEINCNGVIE |
| Q99459 | T510 | Sugiyama | CDC5L KIAA0432 PCDC5RP | FEIVLPENAEKELEEREIDDtyIEDAADVDARKQAIRDAER |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99614 | S83 | Sugiyama | TTC1 TPR1 | FHDCsAsFEEEPGADKVENKsNEDVNssELDEEyLIELEKN |
| Q99614 | S90 | Sugiyama | TTC1 TPR1 | FEEEPGADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQ |
| Q99733 | S121 | Sugiyama | NAP1L4 NAP2 | PLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKV |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BVS4 | S332 | Sugiyama | RIOK2 RIO2 | DDELLHPLGPDDKNIETKEGsEFsFsDGEVAEKAEVyGsEN |
| Q9BVS4 | S335 | Sugiyama | RIOK2 RIO2 | LLHPLGPDDKNIETKEGsEFsFsDGEVAEKAEVyGsENEsE |
| Q9BW91 | S343 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | SHSQFIKLVAEKRDAHWSEDsEADCHAL_____________ |
| Q9BXJ9 | T850 | Sugiyama | NAA15 GA19 NARG1 NATH TBDN100 | KLFPYALAFMPPGYEEDMKItVNGDssAEAEELANEI____ |
| Q9BXK5 | S420 | Sugiyama | BCL2L13 MIL1 CD003 | PALEPTETLLsEKEINAREEsLVEELsPAsEKKPVPPSEGK |
| Q9BXW9 | S891 | Sugiyama | FANCD2 FACD | KQKTDGSKTSssDtLsEEKNsECDPtPsHRGQLNKEFTGKE |
| Q9BXW9 | T884 | Sugiyama | FANCD2 FACD | KKGKIERKQKTDGSKTSssDtLsEEKNsECDPtPsHRGQLN |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9H2U2 | S309 | Sugiyama | PPA2 HSPC124 | NCTNVQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVW |
| Q9HAU0 | S832 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | ELttVAEVDEsNGEEKsEPVsEIEtsVVKGSHFPVGVVPPR |
| Q9HCN4 | S338 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | HPsDLILtRGTLDEEDEEADsDtDDIDHRVTEESHEEPAFQ |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NR30 | S168 | Sugiyama | DDX21 | PKLKNGFPHPEPDCNPsEAAsEEsNsEIEQEIPVEQKEGAF |
| Q9NRF8 | S574 | Sugiyama | CTPS2 | YLQQGCKLsssDRysDAsDDsFSEPRIAELEIS________ |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NVR5 | S773 | Sugiyama | DNAAF2 C14orf104 KTU | EFIKEKSATCSNEEKDNLNEsVITEEKETDGDHLsSLLNKT |
| Q9NYL9 | S25 | Sugiyama | TMOD3 | FRKDLEKyKDLDEDELLGNLsEtELKQLETVLDDLDPENAL |
| Q9NZ53 | S596 | Sugiyama | PODXL2 UNQ1861/PRO3742 | ALNGPGsWGALMGGKRDPEDsDVFEEDtHL___________ |
| Q9NZ53 | T603 | Sugiyama | PODXL2 UNQ1861/PRO3742 | WGALMGGKRDPEDsDVFEEDtHL__________________ |
| Q9P2I0 | S423 | Sugiyama | CPSF2 CPSF100 KIAA1367 | KEAAKKLEQSKEADIDssDEsDIEEDIDQPSAHKTKHDLMM |
| Q9Y265 | S434 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | NLLAKINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKY |
| Q9Y266 | S285 | Sugiyama | NUDC | NtKKINPENsKLsDLDsEtRsMVEKMMYDQRQKsMGLPtsD |
| Q9Y266 | T283 | Sugiyama | NUDC | EINtKKINPENsKLsDLDsEtRsMVEKMMYDQRQKsMGLPt |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2R5 | S127 | Sugiyama | MRPS17 RPMS17 HSPC011 | ESPLSSETTQLSKNLEELNIssAQ_________________ |
| Q9Y3F4 | S335 | Sugiyama | STRAP MAWD UNRIP | LAKPKIGFPETTEEELEEIAsENsDCIFPSAPDVKA_____ |
| Q9Y4L1 | S763 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | LEAFIFEtQDKLyQPEyQEVsTEEQREEISGKLSAASTWLE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 6.826131e-10 | 9.166 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.075038e-09 | 8.216 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.146041e-08 | 7.668 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.946768e-07 | 6.711 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.915575e-07 | 6.407 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.721753e-07 | 6.429 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.675729e-07 | 6.062 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.182141e-06 | 5.927 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.347005e-06 | 5.871 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.411201e-06 | 5.850 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.205085e-06 | 5.376 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.056789e-06 | 5.392 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.340051e-06 | 5.363 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.602655e-06 | 5.337 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.882787e-06 | 5.103 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.649219e-06 | 5.016 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.439453e-05 | 4.842 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.803053e-05 | 4.744 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.718303e-05 | 4.765 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.074547e-05 | 4.683 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.013982e-05 | 4.696 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.393459e-05 | 4.621 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.393459e-05 | 4.621 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.926346e-05 | 4.534 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.306865e-05 | 4.481 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.677571e-05 | 4.434 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.035523e-05 | 4.394 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.111302e-05 | 4.386 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.935978e-05 | 4.307 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.105075e-05 | 4.214 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.156939e-05 | 4.211 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.450446e-05 | 4.190 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.788180e-05 | 4.056 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.416949e-05 | 4.026 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.051767e-04 | 3.978 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.296892e-04 | 3.887 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.296892e-04 | 3.887 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.379907e-04 | 3.860 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.347261e-04 | 3.871 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.379907e-04 | 3.860 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.565958e-04 | 3.805 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.679374e-04 | 3.775 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.710410e-04 | 3.767 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.714628e-04 | 3.766 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.904078e-04 | 3.720 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.944118e-04 | 3.711 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.127079e-04 | 3.672 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.989855e-04 | 3.524 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.989855e-04 | 3.524 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.943487e-04 | 3.531 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.082247e-04 | 3.511 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.320169e-04 | 3.479 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.488363e-04 | 3.457 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.488363e-04 | 3.457 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.521242e-04 | 3.453 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.969503e-04 | 3.401 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.850893e-04 | 3.414 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.058225e-04 | 3.392 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.462421e-04 | 3.350 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.451511e-04 | 3.351 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.609493e-04 | 3.336 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.700718e-04 | 3.328 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.141053e-04 | 3.289 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.815647e-04 | 3.235 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.815647e-04 | 3.235 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.776088e-04 | 3.169 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.006537e-04 | 3.154 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.118046e-04 | 3.148 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.370517e-04 | 3.133 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.538345e-04 | 3.123 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.069009e-04 | 3.093 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.327352e-04 | 3.030 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.059704e-03 | 2.975 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.059704e-03 | 2.975 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.083710e-03 | 2.965 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.089136e-03 | 2.963 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.202306e-03 | 2.920 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.143565e-03 | 2.942 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.201713e-03 | 2.920 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.208177e-03 | 2.918 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.241399e-03 | 2.906 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.241399e-03 | 2.906 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.464622e-03 | 2.834 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.707968e-03 | 2.768 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.695699e-03 | 2.771 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.708833e-03 | 2.767 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.713344e-03 | 2.766 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.713344e-03 | 2.766 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.843096e-03 | 2.734 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.843096e-03 | 2.734 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.920165e-03 | 2.717 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.962578e-03 | 2.707 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.138788e-03 | 2.670 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.149399e-03 | 2.668 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.227524e-03 | 2.652 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.348512e-03 | 2.629 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.382400e-03 | 2.623 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.348512e-03 | 2.629 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.486493e-03 | 2.604 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.500493e-03 | 2.602 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.725733e-03 | 2.565 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.725733e-03 | 2.565 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.725733e-03 | 2.565 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.725733e-03 | 2.565 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.707493e-03 | 2.567 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.863553e-03 | 2.543 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.023303e-03 | 2.520 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.071534e-03 | 2.513 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.044567e-03 | 2.516 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.089100e-03 | 2.510 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.089100e-03 | 2.510 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.140691e-03 | 2.503 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.305825e-03 | 2.481 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.447630e-03 | 2.462 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.456266e-03 | 2.461 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.764114e-03 | 2.424 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.538074e-03 | 2.451 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.507580e-03 | 2.455 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.511803e-03 | 2.454 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.663784e-03 | 2.436 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.014506e-03 | 2.396 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.151141e-03 | 2.382 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.157740e-03 | 2.381 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.389560e-03 | 2.358 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.802084e-03 | 2.319 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.629590e-03 | 2.334 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.561144e-03 | 2.341 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.590706e-03 | 2.338 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.543729e-03 | 2.343 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.802084e-03 | 2.319 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.600291e-03 | 2.337 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.830996e-03 | 2.316 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.830996e-03 | 2.316 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.945473e-03 | 2.306 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.093068e-03 | 2.293 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.093068e-03 | 2.293 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.212107e-03 | 2.283 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.212107e-03 | 2.283 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.560974e-03 | 2.255 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.667618e-03 | 2.247 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.843252e-03 | 2.233 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.843252e-03 | 2.233 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.405433e-03 | 2.193 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.197758e-03 | 2.208 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.420953e-03 | 2.192 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.512768e-03 | 2.186 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.709924e-03 | 2.173 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.293371e-03 | 2.137 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.413637e-03 | 2.130 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 7.413637e-03 | 2.130 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.484238e-03 | 2.126 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.605067e-03 | 2.119 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.740918e-03 | 2.058 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.452699e-03 | 2.073 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.866871e-03 | 2.104 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.184016e-03 | 2.087 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.184016e-03 | 2.087 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.289976e-03 | 2.081 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.740918e-03 | 2.058 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.452699e-03 | 2.073 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.718008e-03 | 2.060 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.740918e-03 | 2.058 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.740918e-03 | 2.058 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.270629e-03 | 2.033 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.316060e-03 | 2.031 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.005686e-02 | 1.998 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.039728e-02 | 1.983 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.059299e-02 | 1.975 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.077433e-02 | 1.968 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.090921e-02 | 1.962 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.112554e-02 | 1.954 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.265563e-02 | 1.898 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.191731e-02 | 1.924 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.126616e-02 | 1.948 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.126616e-02 | 1.948 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.233124e-02 | 1.909 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.212882e-02 | 1.916 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.172345e-02 | 1.931 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.234548e-02 | 1.908 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.159331e-02 | 1.936 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.150329e-02 | 1.939 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.188519e-02 | 1.925 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.277339e-02 | 1.894 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.287357e-02 | 1.890 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.308978e-02 | 1.883 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.356648e-02 | 1.868 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.373926e-02 | 1.862 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.377594e-02 | 1.861 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.441471e-02 | 1.841 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.453088e-02 | 1.838 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.466789e-02 | 1.834 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.466789e-02 | 1.834 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.526910e-02 | 1.816 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.561954e-02 | 1.806 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.639897e-02 | 1.785 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.639897e-02 | 1.785 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.661746e-02 | 1.779 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.691409e-02 | 1.772 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.691409e-02 | 1.772 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.730802e-02 | 1.762 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.752040e-02 | 1.756 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.959919e-02 | 1.708 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.764009e-02 | 1.753 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.764009e-02 | 1.753 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.931588e-02 | 1.714 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.769579e-02 | 1.752 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.010579e-02 | 1.697 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.029177e-02 | 1.693 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.090958e-02 | 1.680 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.102086e-02 | 1.677 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.118537e-02 | 1.674 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.118537e-02 | 1.674 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.202559e-02 | 1.657 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.217009e-02 | 1.654 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.247885e-02 | 1.648 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.307208e-02 | 1.637 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.412348e-02 | 1.618 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.419217e-02 | 1.616 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.440023e-02 | 1.613 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.440023e-02 | 1.613 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.442668e-02 | 1.612 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.467532e-02 | 1.608 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.467532e-02 | 1.608 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.503882e-02 | 1.601 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.722957e-02 | 1.565 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.007713e-02 | 1.522 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.007713e-02 | 1.522 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.167499e-02 | 1.499 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.821242e-02 | 1.550 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.167499e-02 | 1.499 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.158334e-02 | 1.501 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.821242e-02 | 1.550 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.721308e-02 | 1.565 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.848370e-02 | 1.545 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.891821e-02 | 1.539 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.821242e-02 | 1.550 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.771151e-02 | 1.557 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.790438e-02 | 1.554 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.239742e-02 | 1.489 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.250652e-02 | 1.488 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.250652e-02 | 1.488 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.281929e-02 | 1.484 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.281929e-02 | 1.484 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.281929e-02 | 1.484 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.281929e-02 | 1.484 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.281929e-02 | 1.484 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.332557e-02 | 1.477 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.332557e-02 | 1.477 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.357880e-02 | 1.474 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.502837e-02 | 1.456 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.524914e-02 | 1.453 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.536451e-02 | 1.451 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.536451e-02 | 1.451 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.583933e-02 | 1.446 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.583933e-02 | 1.446 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 3.624478e-02 | 1.441 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.624478e-02 | 1.441 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.624478e-02 | 1.441 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.782486e-02 | 1.422 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.124609e-02 | 1.385 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.125571e-02 | 1.385 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.177419e-02 | 1.379 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.180287e-02 | 1.379 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.203548e-02 | 1.376 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.454562e-02 | 1.351 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.454562e-02 | 1.351 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.503359e-02 | 1.346 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.503359e-02 | 1.346 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.503359e-02 | 1.346 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.503359e-02 | 1.346 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.503359e-02 | 1.346 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.617608e-02 | 1.336 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.389949e-02 | 1.358 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.690224e-02 | 1.329 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.803961e-02 | 1.318 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.503359e-02 | 1.346 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.086718e-02 | 1.294 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.984037e-02 | 1.302 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.803961e-02 | 1.318 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.629629e-02 | 1.334 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.751965e-02 | 1.323 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.808634e-02 | 1.318 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.146243e-02 | 1.289 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.232213e-02 | 1.281 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.274102e-02 | 1.278 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.282060e-02 | 1.277 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.282060e-02 | 1.277 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.532480e-02 | 1.257 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.551099e-02 | 1.256 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.762597e-02 | 1.239 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.762597e-02 | 1.239 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.762597e-02 | 1.239 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.762597e-02 | 1.239 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.762597e-02 | 1.239 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.777417e-02 | 1.238 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.968008e-02 | 1.224 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.064115e-02 | 1.217 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.065770e-02 | 1.217 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.065770e-02 | 1.217 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.159601e-02 | 1.210 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.258282e-02 | 1.204 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.264404e-02 | 1.203 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.405258e-02 | 1.193 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.452595e-02 | 1.190 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.452595e-02 | 1.190 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.677973e-02 | 1.175 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.363889e-02 | 1.078 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 8.363889e-02 | 1.078 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.363889e-02 | 1.078 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 8.363889e-02 | 1.078 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.363889e-02 | 1.078 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.363889e-02 | 1.078 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.363889e-02 | 1.078 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.363889e-02 | 1.078 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.363889e-02 | 1.078 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.363889e-02 | 1.078 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.363889e-02 | 1.078 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.363889e-02 | 1.078 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.363889e-02 | 1.078 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.363889e-02 | 1.078 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.240347e-02 | 1.140 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.240347e-02 | 1.140 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 7.240347e-02 | 1.140 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.253236e-02 | 1.139 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.031635e-02 | 1.095 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.114773e-02 | 1.148 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.261397e-02 | 1.083 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.196168e-02 | 1.143 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.212840e-02 | 1.086 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.737123e-02 | 1.111 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.075878e-02 | 1.150 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.729165e-02 | 1.172 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.405656e-02 | 1.130 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.737123e-02 | 1.111 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.107018e-02 | 1.148 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.789782e-02 | 1.108 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.253236e-02 | 1.139 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.015370e-02 | 1.096 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.261397e-02 | 1.083 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.067717e-02 | 1.093 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.203999e-02 | 1.086 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.789782e-02 | 1.108 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.253236e-02 | 1.139 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.270647e-02 | 1.082 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.501384e-02 | 1.125 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.478030e-02 | 1.072 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.610312e-02 | 1.065 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.610312e-02 | 1.065 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.795632e-02 | 1.056 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.970023e-02 | 1.047 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.989451e-02 | 1.046 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.989451e-02 | 1.046 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.307825e-02 | 1.031 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.307825e-02 | 1.031 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.307825e-02 | 1.031 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.460105e-02 | 1.024 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 9.460105e-02 | 1.024 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 9.472494e-02 | 1.024 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.472494e-02 | 1.024 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.472494e-02 | 1.024 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.504320e-02 | 1.022 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.790923e-02 | 1.009 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.832247e-02 | 1.007 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.002882e-01 | 0.999 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.002882e-01 | 0.999 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.002882e-01 | 0.999 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.002882e-01 | 0.999 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.008297e-01 | 0.996 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.019353e-01 | 0.992 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.036938e-01 | 0.984 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.036938e-01 | 0.984 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.048004e-01 | 0.980 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.126774e-01 | 0.948 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.126774e-01 | 0.948 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.126774e-01 | 0.948 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.126774e-01 | 0.948 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.126774e-01 | 0.948 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.126774e-01 | 0.948 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.126774e-01 | 0.948 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.211289e-01 | 0.917 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.211289e-01 | 0.917 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.211289e-01 | 0.917 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.194692e-01 | 0.923 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.194692e-01 | 0.923 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.194692e-01 | 0.923 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.273819e-01 | 0.895 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.273819e-01 | 0.895 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.273819e-01 | 0.895 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.100853e-01 | 0.958 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.267107e-01 | 0.897 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.267107e-01 | 0.897 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.267107e-01 | 0.897 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.084130e-01 | 0.965 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.084130e-01 | 0.965 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.084130e-01 | 0.965 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.226924e-01 | 0.911 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.113263e-01 | 0.953 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.304891e-01 | 0.884 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.052528e-01 | 0.978 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.184543e-01 | 0.926 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.298762e-01 | 0.886 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.052836e-01 | 0.978 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.210081e-01 | 0.917 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.309900e-01 | 0.883 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.075194e-01 | 0.969 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.156603e-01 | 0.937 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.239586e-01 | 0.907 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.184543e-01 | 0.926 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.100853e-01 | 0.958 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.127527e-01 | 0.948 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.194692e-01 | 0.923 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.226924e-01 | 0.911 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.395441e-01 | 0.855 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.113263e-01 | 0.953 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.052836e-01 | 0.978 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.398294e-01 | 0.854 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.273819e-01 | 0.895 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.378426e-01 | 0.861 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.226924e-01 | 0.911 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.352812e-01 | 0.869 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.094173e-01 | 0.961 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.212368e-01 | 0.916 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.237313e-01 | 0.908 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.400344e-01 | 0.854 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.266110e-01 | 0.898 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.110969e-01 | 0.954 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.211289e-01 | 0.917 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.267107e-01 | 0.897 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.392813e-01 | 0.856 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.147603e-01 | 0.940 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.184543e-01 | 0.926 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.226924e-01 | 0.911 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.184543e-01 | 0.926 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.194692e-01 | 0.923 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.444061e-01 | 0.840 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.444061e-01 | 0.840 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.444073e-01 | 0.840 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.444073e-01 | 0.840 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.444073e-01 | 0.840 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.462949e-01 | 0.835 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.462949e-01 | 0.835 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.462949e-01 | 0.835 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.481615e-01 | 0.829 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.481615e-01 | 0.829 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.481615e-01 | 0.829 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.485627e-01 | 0.828 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.486450e-01 | 0.828 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.486450e-01 | 0.828 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.486450e-01 | 0.828 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.486450e-01 | 0.828 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.486450e-01 | 0.828 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.500893e-01 | 0.824 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.506008e-01 | 0.822 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.506008e-01 | 0.822 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.507779e-01 | 0.822 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.507779e-01 | 0.822 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.538181e-01 | 0.813 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.538181e-01 | 0.813 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.545050e-01 | 0.811 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.556412e-01 | 0.808 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.574171e-01 | 0.803 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.583444e-01 | 0.800 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.589972e-01 | 0.799 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.615645e-01 | 0.792 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.618071e-01 | 0.791 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.618071e-01 | 0.791 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.618071e-01 | 0.791 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.618071e-01 | 0.791 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.618071e-01 | 0.791 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.618071e-01 | 0.791 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.618071e-01 | 0.791 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.618071e-01 | 0.791 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.630957e-01 | 0.788 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.630957e-01 | 0.788 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.692716e-01 | 0.771 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.705670e-01 | 0.768 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.711576e-01 | 0.767 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.711576e-01 | 0.767 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.711576e-01 | 0.767 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.711576e-01 | 0.767 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.742261e-01 | 0.759 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.742261e-01 | 0.759 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.748520e-01 | 0.757 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.748520e-01 | 0.757 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.748520e-01 | 0.757 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.748520e-01 | 0.757 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.748520e-01 | 0.757 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.748520e-01 | 0.757 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.748520e-01 | 0.757 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.755558e-01 | 0.756 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.780812e-01 | 0.749 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.796688e-01 | 0.746 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.826888e-01 | 0.738 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.846328e-01 | 0.734 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.870637e-01 | 0.728 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.880327e-01 | 0.726 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.126644e-01 | 0.672 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.126644e-01 | 0.672 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.126644e-01 | 0.672 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.126644e-01 | 0.672 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.126644e-01 | 0.672 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.126644e-01 | 0.672 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.126644e-01 | 0.672 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.126644e-01 | 0.672 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.044799e-01 | 0.689 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.044799e-01 | 0.689 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.044799e-01 | 0.689 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.044799e-01 | 0.689 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.044799e-01 | 0.689 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.044799e-01 | 0.689 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.044799e-01 | 0.689 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.481820e-01 | 0.605 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.481820e-01 | 0.605 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.481820e-01 | 0.605 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.047941e-01 | 0.689 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.047941e-01 | 0.689 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.047941e-01 | 0.689 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.947603e-01 | 0.710 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.947603e-01 | 0.710 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.947603e-01 | 0.710 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.947603e-01 | 0.710 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.192897e-01 | 0.659 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.192897e-01 | 0.659 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.030939e-01 | 0.692 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.030939e-01 | 0.692 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.445812e-01 | 0.612 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.242140e-01 | 0.649 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.061540e-01 | 0.686 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.061540e-01 | 0.686 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.061540e-01 | 0.686 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.459498e-01 | 0.609 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.248666e-01 | 0.648 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.248666e-01 | 0.648 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.248666e-01 | 0.648 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.064344e-01 | 0.685 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.233251e-01 | 0.651 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.637973e-01 | 0.579 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.999622e-01 | 0.699 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.522644e-01 | 0.598 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.009158e-01 | 0.697 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.486228e-01 | 0.604 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.047941e-01 | 0.689 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.291862e-01 | 0.640 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.192897e-01 | 0.659 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.406768e-01 | 0.619 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.061540e-01 | 0.686 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.291862e-01 | 0.640 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.704728e-01 | 0.568 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.044799e-01 | 0.689 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.044799e-01 | 0.689 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.481820e-01 | 0.605 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.177094e-01 | 0.662 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.682010e-01 | 0.572 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.967080e-01 | 0.706 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.967080e-01 | 0.706 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.967080e-01 | 0.706 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.967080e-01 | 0.706 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.467274e-01 | 0.608 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.842829e-01 | 0.546 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.920654e-01 | 0.717 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.218582e-01 | 0.654 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.469662e-01 | 0.607 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.947603e-01 | 0.710 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.044799e-01 | 0.689 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.192897e-01 | 0.659 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.242140e-01 | 0.649 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.679405e-01 | 0.572 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.011358e-01 | 0.697 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.707200e-01 | 0.567 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.119133e-01 | 0.674 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.704728e-01 | 0.568 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.526616e-01 | 0.597 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.011358e-01 | 0.697 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.291862e-01 | 0.640 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.006134e-01 | 0.698 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.481820e-01 | 0.605 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.704728e-01 | 0.568 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.584402e-01 | 0.588 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.765820e-01 | 0.558 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.584402e-01 | 0.588 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.047941e-01 | 0.689 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.901230e-01 | 0.721 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.967080e-01 | 0.706 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.355876e-01 | 0.628 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.445812e-01 | 0.612 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.550153e-01 | 0.593 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.192897e-01 | 0.659 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.044799e-01 | 0.689 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.061540e-01 | 0.686 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.013897e-01 | 0.521 | 0 | 0 |
| Defective CD320 causes MMATC | R-HSA-3359485 | 3.013897e-01 | 0.521 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 3.013897e-01 | 0.521 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.013897e-01 | 0.521 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.013897e-01 | 0.521 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.801211e-01 | 0.420 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.801211e-01 | 0.420 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.801211e-01 | 0.420 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.801211e-01 | 0.420 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.801211e-01 | 0.420 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.801211e-01 | 0.420 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.921402e-01 | 0.534 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.921402e-01 | 0.534 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.921402e-01 | 0.534 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.357421e-01 | 0.474 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.357421e-01 | 0.474 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.357421e-01 | 0.474 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.357421e-01 | 0.474 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.357421e-01 | 0.474 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.499838e-01 | 0.347 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.499838e-01 | 0.347 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.499838e-01 | 0.347 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.499838e-01 | 0.347 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.996941e-01 | 0.523 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.996941e-01 | 0.523 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.785102e-01 | 0.422 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.785102e-01 | 0.422 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.785102e-01 | 0.422 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.785102e-01 | 0.422 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.785102e-01 | 0.422 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.320511e-01 | 0.479 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.320511e-01 | 0.479 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.320511e-01 | 0.479 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.968068e-01 | 0.528 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.968068e-01 | 0.528 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.643510e-01 | 0.438 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.200788e-01 | 0.377 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.200788e-01 | 0.377 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.200788e-01 | 0.377 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.119763e-01 | 0.291 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.119763e-01 | 0.291 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.119763e-01 | 0.291 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.963834e-01 | 0.402 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.963834e-01 | 0.402 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.370574e-01 | 0.472 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.769948e-01 | 0.424 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.769948e-01 | 0.424 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.601753e-01 | 0.337 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.601753e-01 | 0.337 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.603920e-01 | 0.443 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.032380e-01 | 0.518 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.032380e-01 | 0.518 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.279647e-01 | 0.369 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.279647e-01 | 0.369 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.279647e-01 | 0.369 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.325887e-01 | 0.478 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.325887e-01 | 0.478 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.325887e-01 | 0.478 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.837675e-01 | 0.416 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.837675e-01 | 0.416 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.666973e-01 | 0.436 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.144370e-01 | 0.502 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.940803e-01 | 0.532 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.708032e-01 | 0.431 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.708032e-01 | 0.431 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.708032e-01 | 0.431 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.071005e-01 | 0.390 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.071005e-01 | 0.390 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.301324e-01 | 0.366 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 4.589376e-01 | 0.338 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.986036e-01 | 0.302 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.986036e-01 | 0.302 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.986036e-01 | 0.302 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.986036e-01 | 0.302 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.986036e-01 | 0.302 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.986036e-01 | 0.302 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.669848e-01 | 0.246 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.669848e-01 | 0.246 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.669848e-01 | 0.246 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.669848e-01 | 0.246 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.086824e-01 | 0.389 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.303128e-01 | 0.366 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.562659e-01 | 0.341 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.092484e-01 | 0.388 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.920471e-01 | 0.407 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.891690e-01 | 0.311 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.352304e-01 | 0.271 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.352304e-01 | 0.271 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.352304e-01 | 0.271 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.352304e-01 | 0.271 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.352304e-01 | 0.271 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.352304e-01 | 0.271 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.352304e-01 | 0.271 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.475547e-01 | 0.349 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.883724e-01 | 0.411 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.185489e-01 | 0.285 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.665489e-01 | 0.331 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.072050e-01 | 0.295 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.072050e-01 | 0.295 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.302843e-01 | 0.366 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.914318e-01 | 0.309 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.662306e-01 | 0.331 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.469885e-01 | 0.262 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.699737e-01 | 0.244 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.699737e-01 | 0.244 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.699737e-01 | 0.244 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.699737e-01 | 0.244 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.699737e-01 | 0.244 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.699737e-01 | 0.244 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.699737e-01 | 0.244 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.558870e-01 | 0.255 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.558870e-01 | 0.255 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.633824e-01 | 0.249 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.039093e-01 | 0.517 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.883724e-01 | 0.411 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.533315e-01 | 0.344 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.325887e-01 | 0.478 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.516430e-01 | 0.454 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.532812e-01 | 0.452 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.949984e-01 | 0.530 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.352304e-01 | 0.271 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.601753e-01 | 0.337 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.325887e-01 | 0.478 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.769948e-01 | 0.424 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.303128e-01 | 0.366 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.909150e-01 | 0.309 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.325887e-01 | 0.478 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.502061e-01 | 0.456 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.032380e-01 | 0.518 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.896690e-01 | 0.538 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.144370e-01 | 0.502 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.975105e-01 | 0.303 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.314004e-01 | 0.275 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.589376e-01 | 0.338 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.469885e-01 | 0.262 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.357421e-01 | 0.474 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.357421e-01 | 0.474 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.502061e-01 | 0.456 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.249235e-01 | 0.488 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.601753e-01 | 0.337 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.136903e-01 | 0.503 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.986036e-01 | 0.302 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.086824e-01 | 0.389 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.185489e-01 | 0.285 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.968068e-01 | 0.528 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.753592e-01 | 0.426 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.434674e-01 | 0.353 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.119763e-01 | 0.291 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.325887e-01 | 0.478 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.589376e-01 | 0.338 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.352304e-01 | 0.271 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.469885e-01 | 0.262 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.699737e-01 | 0.244 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.731769e-01 | 0.428 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.352304e-01 | 0.271 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.352304e-01 | 0.271 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.699737e-01 | 0.244 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.056871e-01 | 0.392 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.881535e-01 | 0.411 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 3.138519e-01 | 0.503 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.036746e-01 | 0.394 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.710280e-01 | 0.327 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.423643e-01 | 0.354 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.405933e-01 | 0.267 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.234322e-01 | 0.490 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.200788e-01 | 0.377 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.249235e-01 | 0.488 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.589376e-01 | 0.338 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.986036e-01 | 0.302 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.669848e-01 | 0.246 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.913591e-01 | 0.407 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.891690e-01 | 0.311 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.891690e-01 | 0.311 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.475547e-01 | 0.349 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.185489e-01 | 0.285 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.699737e-01 | 0.244 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.666973e-01 | 0.436 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.173939e-01 | 0.286 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.608595e-01 | 0.443 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.896579e-01 | 0.409 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.892426e-01 | 0.410 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.634536e-01 | 0.440 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.669848e-01 | 0.246 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.270303e-01 | 0.370 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.072050e-01 | 0.295 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.603920e-01 | 0.443 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.490888e-01 | 0.348 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.502061e-01 | 0.456 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.818813e-01 | 0.317 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.633824e-01 | 0.249 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.205858e-01 | 0.284 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.200788e-01 | 0.377 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.119763e-01 | 0.291 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.370574e-01 | 0.472 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.279647e-01 | 0.369 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.476043e-01 | 0.262 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.401206e-01 | 0.268 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.765431e-01 | 0.424 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.589376e-01 | 0.338 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.890710e-01 | 0.539 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.352304e-01 | 0.271 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.917573e-01 | 0.308 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.200788e-01 | 0.377 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.922869e-01 | 0.406 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.303083e-01 | 0.275 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.727828e-01 | 0.325 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.452626e-01 | 0.462 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.963834e-01 | 0.402 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.469885e-01 | 0.262 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.994842e-01 | 0.301 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.963834e-01 | 0.402 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.314004e-01 | 0.275 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.408672e-01 | 0.356 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.215616e-01 | 0.375 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.013897e-01 | 0.521 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.801211e-01 | 0.420 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.499838e-01 | 0.347 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.785102e-01 | 0.422 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.234322e-01 | 0.490 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.138519e-01 | 0.503 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.279647e-01 | 0.369 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 2.992625e-01 | 0.524 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.589376e-01 | 0.338 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.669848e-01 | 0.246 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.352304e-01 | 0.271 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.352304e-01 | 0.271 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.352304e-01 | 0.271 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.318595e-01 | 0.274 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.699737e-01 | 0.244 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.422191e-01 | 0.266 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.342095e-01 | 0.272 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.325829e-01 | 0.274 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.670375e-01 | 0.331 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.528352e-01 | 0.452 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.917573e-01 | 0.308 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.421649e-01 | 0.354 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.643510e-01 | 0.438 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.486408e-01 | 0.261 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.649673e-01 | 0.333 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.469885e-01 | 0.262 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.699737e-01 | 0.244 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.769948e-01 | 0.424 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.040245e-01 | 0.298 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.601753e-01 | 0.337 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.249235e-01 | 0.488 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.861076e-01 | 0.543 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.269599e-01 | 0.278 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.785102e-01 | 0.422 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.119763e-01 | 0.291 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.669848e-01 | 0.246 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.321310e-01 | 0.479 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.699737e-01 | 0.244 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.603920e-01 | 0.443 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.452626e-01 | 0.462 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.452626e-01 | 0.462 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 3.320511e-01 | 0.479 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.891690e-01 | 0.311 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.318595e-01 | 0.274 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.032380e-01 | 0.518 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.968068e-01 | 0.528 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.975105e-01 | 0.303 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.381123e-01 | 0.471 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.662124e-01 | 0.436 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.566332e-01 | 0.340 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.013897e-01 | 0.521 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.921402e-01 | 0.534 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.785102e-01 | 0.422 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.200788e-01 | 0.377 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.119763e-01 | 0.291 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.119763e-01 | 0.291 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.769948e-01 | 0.424 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.601753e-01 | 0.337 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.301324e-01 | 0.366 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.589376e-01 | 0.338 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 4.986036e-01 | 0.302 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.669848e-01 | 0.246 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.352304e-01 | 0.271 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.912847e-01 | 0.536 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.115695e-01 | 0.291 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.486408e-01 | 0.261 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.921402e-01 | 0.534 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.249235e-01 | 0.488 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.469885e-01 | 0.262 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.405859e-01 | 0.267 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.603920e-01 | 0.443 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.510089e-01 | 0.346 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.205858e-01 | 0.284 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.119763e-01 | 0.291 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.601753e-01 | 0.337 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.986036e-01 | 0.302 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.669848e-01 | 0.246 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.301324e-01 | 0.366 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.301324e-01 | 0.366 | 0 | 0 |
| NGF processing | R-HSA-167060 | 4.499838e-01 | 0.347 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 4.499838e-01 | 0.347 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.643510e-01 | 0.438 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.200788e-01 | 0.377 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.200788e-01 | 0.377 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.352304e-01 | 0.271 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.664297e-01 | 0.436 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.699737e-01 | 0.244 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.523526e-01 | 0.453 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.279647e-01 | 0.369 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.270303e-01 | 0.370 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.891690e-01 | 0.311 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.699737e-01 | 0.244 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.441167e-01 | 0.264 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.699737e-01 | 0.244 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.601753e-01 | 0.337 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 3.801211e-01 | 0.420 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.699737e-01 | 0.244 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.669848e-01 | 0.246 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.699981e-01 | 0.244 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.707779e-01 | 0.244 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.744178e-01 | 0.241 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.744178e-01 | 0.241 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.744178e-01 | 0.241 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.758656e-01 | 0.240 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.770754e-01 | 0.239 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.792369e-01 | 0.237 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.840378e-01 | 0.234 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.866575e-01 | 0.232 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.870023e-01 | 0.231 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.887019e-01 | 0.230 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.887019e-01 | 0.230 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.887019e-01 | 0.230 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.897751e-01 | 0.229 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.920993e-01 | 0.228 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.931723e-01 | 0.227 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.931967e-01 | 0.227 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.975193e-01 | 0.224 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.975193e-01 | 0.224 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.981412e-01 | 0.223 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.007845e-01 | 0.221 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.007845e-01 | 0.221 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.007845e-01 | 0.221 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.008688e-01 | 0.221 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.018674e-01 | 0.220 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.018674e-01 | 0.220 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.018674e-01 | 0.220 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.018674e-01 | 0.220 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.027928e-01 | 0.220 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.027928e-01 | 0.220 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.027928e-01 | 0.220 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.027928e-01 | 0.220 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.069733e-01 | 0.217 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.157958e-01 | 0.211 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.157958e-01 | 0.211 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.157958e-01 | 0.211 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.157958e-01 | 0.211 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.157958e-01 | 0.211 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.157958e-01 | 0.211 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.157958e-01 | 0.211 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.157958e-01 | 0.211 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.157958e-01 | 0.211 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.157958e-01 | 0.211 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.157958e-01 | 0.211 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.157958e-01 | 0.211 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.157958e-01 | 0.211 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.157958e-01 | 0.211 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.164246e-01 | 0.210 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.164246e-01 | 0.210 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.207570e-01 | 0.207 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.237453e-01 | 0.205 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.259260e-01 | 0.203 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.260516e-01 | 0.203 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.260516e-01 | 0.203 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.260516e-01 | 0.203 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.260516e-01 | 0.203 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.308862e-01 | 0.200 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.336799e-01 | 0.198 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.336799e-01 | 0.198 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.336799e-01 | 0.198 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.436184e-01 | 0.191 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.448452e-01 | 0.191 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.448452e-01 | 0.191 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.448452e-01 | 0.191 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.456668e-01 | 0.190 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.460470e-01 | 0.190 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.469654e-01 | 0.189 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.501960e-01 | 0.187 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.501960e-01 | 0.187 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.547694e-01 | 0.184 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.591072e-01 | 0.181 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.591072e-01 | 0.181 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.591072e-01 | 0.181 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.591072e-01 | 0.181 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.591072e-01 | 0.181 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.591072e-01 | 0.181 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.591072e-01 | 0.181 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.591072e-01 | 0.181 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 6.591072e-01 | 0.181 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.591072e-01 | 0.181 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.591072e-01 | 0.181 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.591072e-01 | 0.181 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.591072e-01 | 0.181 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.591072e-01 | 0.181 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.591072e-01 | 0.181 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.591072e-01 | 0.181 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.591072e-01 | 0.181 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.610052e-01 | 0.180 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.610052e-01 | 0.180 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.610052e-01 | 0.180 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.610052e-01 | 0.180 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.626535e-01 | 0.179 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.626535e-01 | 0.179 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.626535e-01 | 0.179 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.626535e-01 | 0.179 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.626535e-01 | 0.179 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.626535e-01 | 0.179 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.626535e-01 | 0.179 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.626535e-01 | 0.179 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.626535e-01 | 0.179 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.626535e-01 | 0.179 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.626535e-01 | 0.179 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.626535e-01 | 0.179 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.626535e-01 | 0.179 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.641665e-01 | 0.178 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.651487e-01 | 0.177 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.712892e-01 | 0.173 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 6.726147e-01 | 0.172 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.732062e-01 | 0.172 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.732062e-01 | 0.172 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.732062e-01 | 0.172 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.732062e-01 | 0.172 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.732062e-01 | 0.172 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.732062e-01 | 0.172 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.754671e-01 | 0.170 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.754671e-01 | 0.170 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.819452e-01 | 0.166 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.846442e-01 | 0.165 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.853298e-01 | 0.164 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.865605e-01 | 0.163 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.882802e-01 | 0.162 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.897526e-01 | 0.161 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.897526e-01 | 0.161 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.897526e-01 | 0.161 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.897526e-01 | 0.161 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.897526e-01 | 0.161 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.897526e-01 | 0.161 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.908269e-01 | 0.161 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.908269e-01 | 0.161 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.908269e-01 | 0.161 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.911708e-01 | 0.160 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.950814e-01 | 0.158 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.950814e-01 | 0.158 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.950814e-01 | 0.158 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.950814e-01 | 0.158 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.958282e-01 | 0.157 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.971474e-01 | 0.157 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 6.975383e-01 | 0.156 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.975383e-01 | 0.156 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.975383e-01 | 0.156 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.975383e-01 | 0.156 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 6.975383e-01 | 0.156 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.975383e-01 | 0.156 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.975383e-01 | 0.156 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.975383e-01 | 0.156 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.975383e-01 | 0.156 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.975383e-01 | 0.156 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.975383e-01 | 0.156 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.975383e-01 | 0.156 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.975383e-01 | 0.156 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.975383e-01 | 0.156 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.975383e-01 | 0.156 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.975383e-01 | 0.156 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.975383e-01 | 0.156 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.001281e-01 | 0.155 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.033257e-01 | 0.153 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.086640e-01 | 0.150 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.133117e-01 | 0.147 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.150314e-01 | 0.146 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.150314e-01 | 0.146 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.150314e-01 | 0.146 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.150314e-01 | 0.146 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.150314e-01 | 0.146 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.158298e-01 | 0.145 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.158298e-01 | 0.145 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.158298e-01 | 0.145 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.158298e-01 | 0.145 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.158926e-01 | 0.145 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.165744e-01 | 0.145 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.211928e-01 | 0.142 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.212797e-01 | 0.142 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.212797e-01 | 0.142 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.212797e-01 | 0.142 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.212797e-01 | 0.142 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.281080e-01 | 0.138 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.281080e-01 | 0.138 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.281080e-01 | 0.138 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.300521e-01 | 0.137 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.316389e-01 | 0.136 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.316389e-01 | 0.136 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.316389e-01 | 0.136 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.316389e-01 | 0.136 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.316389e-01 | 0.136 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.316389e-01 | 0.136 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.316389e-01 | 0.136 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.316389e-01 | 0.136 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.316389e-01 | 0.136 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.316389e-01 | 0.136 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.316389e-01 | 0.136 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.316389e-01 | 0.136 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.316389e-01 | 0.136 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.316389e-01 | 0.136 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.316389e-01 | 0.136 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.316389e-01 | 0.136 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.316389e-01 | 0.136 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.316389e-01 | 0.136 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.351246e-01 | 0.134 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.354668e-01 | 0.133 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.354668e-01 | 0.133 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.354668e-01 | 0.133 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.355448e-01 | 0.133 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.376751e-01 | 0.132 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.385120e-01 | 0.132 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.385559e-01 | 0.132 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 7.385559e-01 | 0.132 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.385559e-01 | 0.132 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.397431e-01 | 0.131 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.436681e-01 | 0.129 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.505245e-01 | 0.125 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.540144e-01 | 0.123 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.540144e-01 | 0.123 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.544051e-01 | 0.122 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.545042e-01 | 0.122 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.577873e-01 | 0.120 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.578382e-01 | 0.120 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.578382e-01 | 0.120 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.604003e-01 | 0.119 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.604003e-01 | 0.119 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.604003e-01 | 0.119 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.604003e-01 | 0.119 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.608510e-01 | 0.119 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.618966e-01 | 0.118 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.618966e-01 | 0.118 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.618966e-01 | 0.118 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.618966e-01 | 0.118 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.618966e-01 | 0.118 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.618966e-01 | 0.118 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.618966e-01 | 0.118 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.618966e-01 | 0.118 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.618966e-01 | 0.118 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.618966e-01 | 0.118 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.618966e-01 | 0.118 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.618966e-01 | 0.118 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.618966e-01 | 0.118 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.624958e-01 | 0.118 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.624958e-01 | 0.118 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.699687e-01 | 0.114 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.699687e-01 | 0.114 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.714997e-01 | 0.113 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.714997e-01 | 0.113 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.714997e-01 | 0.113 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.717578e-01 | 0.113 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.717578e-01 | 0.113 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.717578e-01 | 0.113 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.749377e-01 | 0.111 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.751872e-01 | 0.111 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.751872e-01 | 0.111 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.790971e-01 | 0.108 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.806443e-01 | 0.108 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.806443e-01 | 0.108 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.806443e-01 | 0.108 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.806443e-01 | 0.108 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.811294e-01 | 0.107 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.842113e-01 | 0.106 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.842113e-01 | 0.106 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.850576e-01 | 0.105 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.871502e-01 | 0.104 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.871502e-01 | 0.104 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.879542e-01 | 0.103 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.879542e-01 | 0.103 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.879542e-01 | 0.103 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.887443e-01 | 0.103 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.887443e-01 | 0.103 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.887443e-01 | 0.103 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.887443e-01 | 0.103 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.887443e-01 | 0.103 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.887443e-01 | 0.103 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.887443e-01 | 0.103 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.985898e-01 | 0.098 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.985898e-01 | 0.098 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.985898e-01 | 0.098 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.985898e-01 | 0.098 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.989420e-01 | 0.097 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.990287e-01 | 0.097 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.993710e-01 | 0.097 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.993710e-01 | 0.097 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.993710e-01 | 0.097 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.993710e-01 | 0.097 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.996041e-01 | 0.097 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.034123e-01 | 0.095 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.047322e-01 | 0.094 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.079241e-01 | 0.093 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.079241e-01 | 0.093 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.098411e-01 | 0.092 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.115605e-01 | 0.091 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.117838e-01 | 0.091 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.117838e-01 | 0.091 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.117838e-01 | 0.091 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.124656e-01 | 0.090 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.125661e-01 | 0.090 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.125661e-01 | 0.090 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.125661e-01 | 0.090 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.125661e-01 | 0.090 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.125661e-01 | 0.090 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.125661e-01 | 0.090 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.125661e-01 | 0.090 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.125661e-01 | 0.090 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.125661e-01 | 0.090 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.125661e-01 | 0.090 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.144231e-01 | 0.089 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.166651e-01 | 0.088 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.166651e-01 | 0.088 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.166651e-01 | 0.088 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.179114e-01 | 0.087 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.179114e-01 | 0.087 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.203904e-01 | 0.086 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.218454e-01 | 0.085 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.218454e-01 | 0.085 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.242617e-01 | 0.084 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.290965e-01 | 0.081 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.310595e-01 | 0.080 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.314640e-01 | 0.080 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.322910e-01 | 0.080 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.322910e-01 | 0.080 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.322910e-01 | 0.080 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.326116e-01 | 0.080 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.326116e-01 | 0.080 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.326116e-01 | 0.080 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.326116e-01 | 0.080 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.326366e-01 | 0.080 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.337030e-01 | 0.079 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.337030e-01 | 0.079 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 8.337030e-01 | 0.079 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.337030e-01 | 0.079 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.337030e-01 | 0.079 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.337030e-01 | 0.079 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.337030e-01 | 0.079 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.337030e-01 | 0.079 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.337030e-01 | 0.079 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.343132e-01 | 0.079 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.360466e-01 | 0.078 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.360466e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.366245e-01 | 0.077 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.370674e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.370674e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.370674e-01 | 0.077 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.405040e-01 | 0.075 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.407816e-01 | 0.075 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.426786e-01 | 0.074 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.441894e-01 | 0.074 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.445553e-01 | 0.073 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.471627e-01 | 0.072 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.472943e-01 | 0.072 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.472943e-01 | 0.072 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.472943e-01 | 0.072 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.472943e-01 | 0.072 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.500458e-01 | 0.071 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.505694e-01 | 0.070 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.522821e-01 | 0.069 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.524573e-01 | 0.069 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.524573e-01 | 0.069 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.524573e-01 | 0.069 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.524573e-01 | 0.069 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.524573e-01 | 0.069 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.524573e-01 | 0.069 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.524573e-01 | 0.069 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.524573e-01 | 0.069 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.524573e-01 | 0.069 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.525299e-01 | 0.069 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.525299e-01 | 0.069 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.525299e-01 | 0.069 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.554509e-01 | 0.068 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.574155e-01 | 0.067 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.582000e-01 | 0.066 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.607955e-01 | 0.065 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.607955e-01 | 0.065 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.607955e-01 | 0.065 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.618624e-01 | 0.065 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.652396e-01 | 0.063 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.655257e-01 | 0.063 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.671117e-01 | 0.062 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.671117e-01 | 0.062 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.671117e-01 | 0.062 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.671117e-01 | 0.062 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.671117e-01 | 0.062 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.671117e-01 | 0.062 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.671117e-01 | 0.062 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.689675e-01 | 0.061 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.689675e-01 | 0.061 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.690976e-01 | 0.061 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.690976e-01 | 0.061 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.690976e-01 | 0.061 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.690976e-01 | 0.061 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.690976e-01 | 0.061 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.690976e-01 | 0.061 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.690976e-01 | 0.061 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.690976e-01 | 0.061 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.731948e-01 | 0.059 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.731948e-01 | 0.059 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.731948e-01 | 0.059 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.767513e-01 | 0.057 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.767513e-01 | 0.057 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.770601e-01 | 0.057 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.774171e-01 | 0.057 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.774171e-01 | 0.057 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.774171e-01 | 0.057 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.838620e-01 | 0.054 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.838620e-01 | 0.054 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.838620e-01 | 0.054 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.838620e-01 | 0.054 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.838620e-01 | 0.054 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.838620e-01 | 0.054 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.838620e-01 | 0.054 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.838620e-01 | 0.054 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.845690e-01 | 0.053 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.845690e-01 | 0.053 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.850235e-01 | 0.053 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.850235e-01 | 0.053 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.857041e-01 | 0.053 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.863049e-01 | 0.052 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.863049e-01 | 0.052 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.870062e-01 | 0.052 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.870062e-01 | 0.052 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.870062e-01 | 0.052 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.893923e-01 | 0.051 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.936028e-01 | 0.049 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.943667e-01 | 0.048 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.949916e-01 | 0.048 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.949916e-01 | 0.048 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.949916e-01 | 0.048 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.955728e-01 | 0.048 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.959189e-01 | 0.048 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.969619e-01 | 0.047 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.969619e-01 | 0.047 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.969619e-01 | 0.047 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.969619e-01 | 0.047 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.969619e-01 | 0.047 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.969619e-01 | 0.047 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.969619e-01 | 0.047 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.974883e-01 | 0.047 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.012441e-01 | 0.045 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.022467e-01 | 0.045 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.027608e-01 | 0.044 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.031829e-01 | 0.044 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.041940e-01 | 0.044 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.041940e-01 | 0.044 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.045323e-01 | 0.044 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.045323e-01 | 0.044 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.045323e-01 | 0.044 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.045323e-01 | 0.044 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.062406e-01 | 0.043 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.067937e-01 | 0.042 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.083964e-01 | 0.042 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.083964e-01 | 0.042 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.085849e-01 | 0.042 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.085849e-01 | 0.042 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.085849e-01 | 0.042 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.085849e-01 | 0.042 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.085849e-01 | 0.042 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.085849e-01 | 0.042 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.085849e-01 | 0.042 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.085849e-01 | 0.042 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.092679e-01 | 0.041 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.092679e-01 | 0.041 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.116615e-01 | 0.040 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.116615e-01 | 0.040 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.118694e-01 | 0.040 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.118694e-01 | 0.040 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.118694e-01 | 0.040 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.132576e-01 | 0.039 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.132576e-01 | 0.039 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.132576e-01 | 0.039 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.132576e-01 | 0.039 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.188974e-01 | 0.037 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.188974e-01 | 0.037 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.188974e-01 | 0.037 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.188974e-01 | 0.037 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.188974e-01 | 0.037 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.188974e-01 | 0.037 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.188974e-01 | 0.037 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.188974e-01 | 0.037 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.188974e-01 | 0.037 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.200373e-01 | 0.036 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.212300e-01 | 0.036 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.212300e-01 | 0.036 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.212300e-01 | 0.036 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.212300e-01 | 0.036 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.233817e-01 | 0.035 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.255658e-01 | 0.034 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.255658e-01 | 0.034 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.280471e-01 | 0.032 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.280471e-01 | 0.032 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.280471e-01 | 0.032 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.280471e-01 | 0.032 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.280471e-01 | 0.032 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.285081e-01 | 0.032 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.285081e-01 | 0.032 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 9.285081e-01 | 0.032 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.290389e-01 | 0.032 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.306076e-01 | 0.031 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.306737e-01 | 0.031 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.316556e-01 | 0.031 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.316556e-01 | 0.031 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.316556e-01 | 0.031 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.326058e-01 | 0.030 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.351473e-01 | 0.029 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.351473e-01 | 0.029 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.361650e-01 | 0.029 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.361650e-01 | 0.029 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.361650e-01 | 0.029 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.361650e-01 | 0.029 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.361650e-01 | 0.029 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.361650e-01 | 0.029 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.361650e-01 | 0.029 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.361650e-01 | 0.029 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.366094e-01 | 0.028 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.392457e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.400639e-01 | 0.027 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.403979e-01 | 0.027 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.411989e-01 | 0.026 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.411989e-01 | 0.026 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.430675e-01 | 0.025 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.432786e-01 | 0.025 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.433674e-01 | 0.025 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.433674e-01 | 0.025 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.433674e-01 | 0.025 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.433674e-01 | 0.025 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.433674e-01 | 0.025 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.433674e-01 | 0.025 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.458769e-01 | 0.024 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.467110e-01 | 0.024 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.472747e-01 | 0.024 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.484676e-01 | 0.023 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.495664e-01 | 0.022 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.497576e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.497576e-01 | 0.022 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.497576e-01 | 0.022 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.497576e-01 | 0.022 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.502850e-01 | 0.022 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.506329e-01 | 0.022 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.510146e-01 | 0.022 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.516951e-01 | 0.022 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.516951e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.517282e-01 | 0.021 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.517282e-01 | 0.021 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.517282e-01 | 0.021 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.554271e-01 | 0.020 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.554271e-01 | 0.020 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.554271e-01 | 0.020 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.554271e-01 | 0.020 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.554271e-01 | 0.020 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.554271e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.554271e-01 | 0.020 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.554469e-01 | 0.020 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.557674e-01 | 0.020 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.557674e-01 | 0.020 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.557674e-01 | 0.020 | 1 | 1 |
| HCMV Late Events | R-HSA-9610379 | 9.559475e-01 | 0.020 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.562921e-01 | 0.019 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.562921e-01 | 0.019 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.562921e-01 | 0.019 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.562921e-01 | 0.019 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.562921e-01 | 0.019 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.562921e-01 | 0.019 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.562921e-01 | 0.019 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.564923e-01 | 0.019 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.564987e-01 | 0.019 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.571167e-01 | 0.019 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.593265e-01 | 0.018 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.595165e-01 | 0.018 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.595273e-01 | 0.018 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.595273e-01 | 0.018 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.604411e-01 | 0.018 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.604411e-01 | 0.018 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.604411e-01 | 0.018 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.604411e-01 | 0.018 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.604571e-01 | 0.018 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.604571e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.604571e-01 | 0.018 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.604571e-01 | 0.018 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.604571e-01 | 0.018 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.619929e-01 | 0.017 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.629656e-01 | 0.016 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.629656e-01 | 0.016 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.641747e-01 | 0.016 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.642105e-01 | 0.016 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.642105e-01 | 0.016 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.647123e-01 | 0.016 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.649197e-01 | 0.016 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.649197e-01 | 0.016 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.649197e-01 | 0.016 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.649197e-01 | 0.016 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.655676e-01 | 0.015 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.661366e-01 | 0.015 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.664476e-01 | 0.015 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.676333e-01 | 0.014 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.676333e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.676333e-01 | 0.014 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.688789e-01 | 0.014 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.688789e-01 | 0.014 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.707397e-01 | 0.013 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.707397e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.707397e-01 | 0.013 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.717254e-01 | 0.012 | 1 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.723915e-01 | 0.012 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.723915e-01 | 0.012 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.723915e-01 | 0.012 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.723915e-01 | 0.012 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.723915e-01 | 0.012 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.723915e-01 | 0.012 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.723915e-01 | 0.012 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.732627e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.739312e-01 | 0.011 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.741805e-01 | 0.011 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.742272e-01 | 0.011 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.745125e-01 | 0.011 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.755079e-01 | 0.011 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.755079e-01 | 0.011 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.755079e-01 | 0.011 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.755079e-01 | 0.011 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.758989e-01 | 0.011 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.760201e-01 | 0.011 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.761120e-01 | 0.011 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.761120e-01 | 0.011 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.769970e-01 | 0.010 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.782370e-01 | 0.010 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.782726e-01 | 0.010 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.782726e-01 | 0.010 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.782726e-01 | 0.010 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.782726e-01 | 0.010 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.784271e-01 | 0.009 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.784271e-01 | 0.009 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.784271e-01 | 0.009 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.784964e-01 | 0.009 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.805240e-01 | 0.009 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.805240e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.805240e-01 | 0.009 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.807254e-01 | 0.008 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.807254e-01 | 0.008 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.807254e-01 | 0.008 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.807254e-01 | 0.008 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.807254e-01 | 0.008 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.809796e-01 | 0.008 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.821191e-01 | 0.008 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.822469e-01 | 0.008 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.824226e-01 | 0.008 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.829014e-01 | 0.007 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.829014e-01 | 0.007 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.829014e-01 | 0.007 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.830265e-01 | 0.007 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.837039e-01 | 0.007 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.848318e-01 | 0.007 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.855142e-01 | 0.006 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.856871e-01 | 0.006 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.856871e-01 | 0.006 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.856871e-01 | 0.006 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.856954e-01 | 0.006 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.856954e-01 | 0.006 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.856954e-01 | 0.006 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.864794e-01 | 0.006 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.864794e-01 | 0.006 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.865265e-01 | 0.006 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.865265e-01 | 0.006 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.865445e-01 | 0.006 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.869370e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.871011e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.876909e-01 | 0.005 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.877123e-01 | 0.005 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.881170e-01 | 0.005 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.887152e-01 | 0.005 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.894116e-01 | 0.005 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.894116e-01 | 0.005 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.894116e-01 | 0.005 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.900962e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.905576e-01 | 0.004 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.916681e-01 | 0.004 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.916681e-01 | 0.004 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.916681e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.916681e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.917118e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.917118e-01 | 0.004 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.917485e-01 | 0.004 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.922879e-01 | 0.003 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.926091e-01 | 0.003 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.926091e-01 | 0.003 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.926091e-01 | 0.003 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.927787e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.930395e-01 | 0.003 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.931034e-01 | 0.003 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.931034e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.933003e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.934439e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.934831e-01 | 0.003 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.940122e-01 | 0.003 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.941845e-01 | 0.003 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.941845e-01 | 0.003 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.941845e-01 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.947029e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.948414e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.948414e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.948414e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.948666e-01 | 0.002 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.950058e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.953640e-01 | 0.002 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.954242e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.954242e-01 | 0.002 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.957068e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.957068e-01 | 0.002 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.957242e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.960072e-01 | 0.002 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.960072e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.961055e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.963188e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.963428e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.963997e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.963997e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.967363e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.968065e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.969264e-01 | 0.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.969345e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.970446e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.973440e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.974874e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.974874e-01 | 0.001 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.974874e-01 | 0.001 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.974874e-01 | 0.001 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.974874e-01 | 0.001 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.977714e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.977714e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.978559e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.979782e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.980232e-01 | 0.001 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.980232e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.980232e-01 | 0.001 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.982466e-01 | 0.001 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.982466e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.983353e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.984000e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.984448e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.985145e-01 | 0.001 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.985433e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.985643e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.986206e-01 | 0.001 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.988766e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.990016e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.990375e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.990478e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.990921e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.990955e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.990955e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.991222e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.991463e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.991463e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.991885e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.991885e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.992497e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.992788e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.993285e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.993804e-01 | 0.000 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.994044e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.994709e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.994718e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.994718e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.995785e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.996177e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.996219e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996611e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.996732e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.996784e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.997101e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.997101e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.997131e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997142e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.997279e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.997279e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997418e-01 | 0.000 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.997429e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.997429e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.997429e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.997474e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.997564e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.997978e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998044e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.998207e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.998735e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998749e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.998749e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.998749e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.998891e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.998891e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.999098e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999128e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999172e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999226e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999226e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999226e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999337e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999392e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999461e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999483e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999485e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999522e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999677e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999696e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999704e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999731e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999731e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999741e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999785e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999802e-01 | 0.000 | 1 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999831e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999900e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999930e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999940e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999954e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999969e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999970e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999972e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999973e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999979e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999989e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999991e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999991e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999995e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999995e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999996e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999998e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 1 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1-dependent transactivation | R-HSA-3371571 | 1.554312e-15 | 14.808 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.254552e-14 | 13.902 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.121325e-14 | 13.950 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.719247e-11 | 10.765 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.947061e-10 | 9.711 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.678106e-10 | 9.115 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.192632e-09 | 8.659 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.622970e-09 | 8.581 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.001611e-08 | 7.999 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.232391e-08 | 7.909 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.865995e-08 | 7.729 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.030776e-08 | 7.692 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.469853e-07 | 6.833 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.652079e-07 | 6.782 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.778508e-07 | 6.750 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.507727e-07 | 6.601 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.948000e-07 | 6.530 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.492150e-07 | 6.457 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.049968e-07 | 6.218 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.099761e-07 | 6.149 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.829214e-07 | 6.166 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.073584e-07 | 6.042 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.630703e-07 | 6.016 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.026326e-06 | 5.989 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.953330e-06 | 5.709 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.645344e-06 | 5.578 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.142278e-06 | 5.503 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.132371e-06 | 5.504 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.749408e-06 | 5.426 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.756209e-06 | 5.425 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.436567e-06 | 5.353 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.776945e-06 | 5.321 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.584253e-06 | 5.339 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.744656e-06 | 5.324 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.358530e-06 | 5.271 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.241705e-06 | 5.140 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.564397e-06 | 5.121 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.680999e-06 | 5.061 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.087233e-05 | 4.964 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.087233e-05 | 4.964 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.118506e-05 | 4.951 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.265865e-05 | 4.898 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.559323e-05 | 4.807 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.537126e-05 | 4.813 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.608099e-05 | 4.794 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.796292e-05 | 4.746 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.745116e-05 | 4.758 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.923878e-05 | 4.716 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.126627e-05 | 4.672 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.497665e-05 | 4.602 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.851196e-05 | 4.545 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.027334e-05 | 4.519 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.027334e-05 | 4.519 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.137781e-05 | 4.503 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.069054e-05 | 4.513 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.524296e-05 | 4.453 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.465932e-05 | 4.460 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.890011e-05 | 4.410 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.965485e-05 | 4.402 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.665413e-05 | 4.331 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.624698e-05 | 4.250 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.689191e-05 | 4.175 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.654687e-05 | 4.015 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.939156e-04 | 3.712 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.939156e-04 | 3.712 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.932801e-04 | 3.714 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.991756e-04 | 3.701 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.170828e-04 | 3.663 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.156212e-04 | 3.666 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.815650e-04 | 3.550 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.053031e-04 | 3.515 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.102359e-04 | 3.508 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.717300e-04 | 3.430 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.717300e-04 | 3.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.717300e-04 | 3.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.717300e-04 | 3.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.717300e-04 | 3.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.717300e-04 | 3.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.717300e-04 | 3.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.717300e-04 | 3.430 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.717300e-04 | 3.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.717300e-04 | 3.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.717300e-04 | 3.430 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.468304e-04 | 3.460 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.828230e-04 | 3.417 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.241322e-04 | 3.372 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.841815e-04 | 3.315 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.221304e-04 | 3.282 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.006389e-04 | 3.221 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.326120e-04 | 3.199 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.019015e-04 | 3.220 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.389600e-04 | 3.195 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.391735e-04 | 3.194 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.418662e-04 | 3.193 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.945964e-04 | 3.158 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.327222e-04 | 3.135 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.980209e-04 | 3.098 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.235550e-04 | 3.084 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.235550e-04 | 3.084 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.416690e-04 | 3.075 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 8.507161e-04 | 3.070 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.880686e-04 | 3.052 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.052466e-03 | 2.978 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.145983e-03 | 2.941 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.145983e-03 | 2.941 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.145983e-03 | 2.941 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.097794e-03 | 2.959 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.246272e-03 | 2.904 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.269184e-03 | 2.896 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.269184e-03 | 2.896 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.274075e-03 | 2.895 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.463138e-03 | 2.835 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.495589e-03 | 2.825 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.495589e-03 | 2.825 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.531934e-03 | 2.815 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.570726e-03 | 2.804 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.694555e-03 | 2.771 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.736399e-03 | 2.760 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.819256e-03 | 2.740 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.860618e-03 | 2.730 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.878608e-03 | 2.726 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.878608e-03 | 2.726 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.922357e-03 | 2.716 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.951596e-03 | 2.710 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.008659e-03 | 2.697 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.140917e-03 | 2.669 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.306140e-03 | 2.637 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.277490e-03 | 2.643 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.379312e-03 | 2.624 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.490766e-03 | 2.604 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.552518e-03 | 2.593 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.594956e-03 | 2.586 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.673254e-03 | 2.573 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.795640e-03 | 2.554 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.997106e-03 | 2.523 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.756701e-03 | 2.560 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.756701e-03 | 2.560 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.826141e-03 | 2.549 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.912527e-03 | 2.536 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.797634e-03 | 2.553 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.132471e-03 | 2.504 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.132471e-03 | 2.504 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.132471e-03 | 2.504 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.165429e-03 | 2.500 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.413159e-03 | 2.467 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.420919e-03 | 2.466 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.862795e-03 | 2.413 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.123365e-03 | 2.385 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.226241e-03 | 2.374 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.597385e-03 | 2.337 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.666284e-03 | 2.331 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.789170e-03 | 2.320 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.157290e-03 | 2.288 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.328636e-03 | 2.273 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.089942e-03 | 2.293 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.424288e-03 | 2.266 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.525771e-03 | 2.258 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.832615e-03 | 2.234 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.911041e-03 | 2.228 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.911041e-03 | 2.228 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.911041e-03 | 2.228 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.911041e-03 | 2.228 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.019117e-03 | 2.220 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.131842e-03 | 2.212 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.150848e-03 | 2.211 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.168854e-03 | 2.210 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 6.475575e-03 | 2.189 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.730519e-03 | 2.172 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.698379e-03 | 2.114 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.698379e-03 | 2.114 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.698379e-03 | 2.114 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.636280e-03 | 2.117 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.698379e-03 | 2.114 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.047783e-03 | 2.152 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.376675e-03 | 2.077 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 8.558488e-03 | 2.068 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.700045e-03 | 2.060 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.245751e-03 | 2.034 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.257606e-03 | 2.034 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.007762e-02 | 1.997 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.018428e-02 | 1.992 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.087892e-02 | 1.963 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.087892e-02 | 1.963 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.106219e-02 | 1.956 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.106401e-02 | 1.956 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.106401e-02 | 1.956 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.106401e-02 | 1.956 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.106401e-02 | 1.956 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.208393e-02 | 1.918 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.357486e-02 | 1.867 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.279184e-02 | 1.893 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.279184e-02 | 1.893 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.203855e-02 | 1.919 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.279184e-02 | 1.893 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.217456e-02 | 1.915 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.357486e-02 | 1.867 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.279184e-02 | 1.893 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.415761e-02 | 1.849 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.528185e-02 | 1.816 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.538101e-02 | 1.813 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.553333e-02 | 1.809 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.553333e-02 | 1.809 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.628233e-02 | 1.788 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.675088e-02 | 1.776 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.701606e-02 | 1.769 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.728745e-02 | 1.762 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.779234e-02 | 1.750 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.804695e-02 | 1.744 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.827579e-02 | 1.738 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.860359e-02 | 1.730 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.926595e-02 | 1.715 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.968171e-02 | 1.706 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.997485e-02 | 1.700 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.065271e-02 | 1.685 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.065871e-02 | 1.685 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.078016e-02 | 1.682 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.333760e-02 | 1.632 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.333760e-02 | 1.632 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.333760e-02 | 1.632 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.145951e-02 | 1.668 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.333760e-02 | 1.632 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.179246e-02 | 1.662 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.445110e-02 | 1.612 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.122605e-02 | 1.673 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.326006e-02 | 1.633 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.390931e-02 | 1.621 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.457445e-02 | 1.610 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.559491e-02 | 1.592 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.576710e-02 | 1.589 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.576710e-02 | 1.589 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.614124e-02 | 1.583 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.614124e-02 | 1.583 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.740254e-02 | 1.562 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.773472e-02 | 1.557 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.773472e-02 | 1.557 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.773472e-02 | 1.557 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.895680e-02 | 1.538 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.905706e-02 | 1.537 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.977981e-02 | 1.526 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.026520e-02 | 1.519 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.106972e-02 | 1.508 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.106972e-02 | 1.508 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.111358e-02 | 1.507 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.114970e-02 | 1.507 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.183893e-02 | 1.497 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.183893e-02 | 1.497 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.350657e-02 | 1.475 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.387597e-02 | 1.470 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.526003e-02 | 1.453 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.568202e-02 | 1.448 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.899436e-02 | 1.409 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.648640e-02 | 1.438 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.674181e-02 | 1.435 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.674181e-02 | 1.435 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.168210e-02 | 1.380 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.869333e-02 | 1.412 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.173324e-02 | 1.380 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.161359e-02 | 1.381 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.299481e-02 | 1.367 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.902948e-02 | 1.409 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.168210e-02 | 1.380 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.869333e-02 | 1.412 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.315871e-02 | 1.365 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.342942e-02 | 1.362 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.342942e-02 | 1.362 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 4.342942e-02 | 1.362 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.437387e-02 | 1.353 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.451993e-02 | 1.351 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.451993e-02 | 1.351 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.495250e-02 | 1.347 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.495250e-02 | 1.347 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.541097e-02 | 1.343 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.741755e-02 | 1.324 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.741755e-02 | 1.324 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.741755e-02 | 1.324 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.042995e-02 | 1.297 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.087625e-02 | 1.293 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.288231e-02 | 1.277 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.288231e-02 | 1.277 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.342341e-02 | 1.272 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.728235e-02 | 1.242 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.728235e-02 | 1.242 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.728235e-02 | 1.242 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.728235e-02 | 1.242 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.733243e-02 | 1.242 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.742441e-02 | 1.241 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.777800e-02 | 1.238 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 6.435955e-02 | 1.191 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 6.435955e-02 | 1.191 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 6.435955e-02 | 1.191 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.330003e-02 | 1.199 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.544964e-02 | 1.184 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.544964e-02 | 1.184 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.544964e-02 | 1.184 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.414035e-02 | 1.130 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.148073e-02 | 1.146 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.299920e-02 | 1.201 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.823736e-02 | 1.166 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.823736e-02 | 1.166 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.380740e-02 | 1.195 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.737756e-02 | 1.171 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.362076e-02 | 1.196 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.737756e-02 | 1.171 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.556200e-02 | 1.183 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.126308e-02 | 1.147 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.401710e-02 | 1.131 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.846968e-02 | 1.165 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.322621e-02 | 1.135 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 6.435955e-02 | 1.191 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.544964e-02 | 1.184 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.544964e-02 | 1.184 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.716666e-02 | 1.173 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.470933e-02 | 1.127 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.470933e-02 | 1.127 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.326226e-02 | 1.135 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.414035e-02 | 1.130 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.502442e-02 | 1.125 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.502442e-02 | 1.125 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.521684e-02 | 1.124 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.752317e-02 | 1.111 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.752317e-02 | 1.111 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.752317e-02 | 1.111 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.752317e-02 | 1.111 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.752317e-02 | 1.111 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.780019e-02 | 1.109 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.822865e-02 | 1.107 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 7.881929e-02 | 1.103 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 7.881929e-02 | 1.103 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 7.881929e-02 | 1.103 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 7.881929e-02 | 1.103 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 7.881929e-02 | 1.103 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 7.881929e-02 | 1.103 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 7.881929e-02 | 1.103 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 7.881929e-02 | 1.103 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 7.881929e-02 | 1.103 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 7.881929e-02 | 1.103 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 7.881929e-02 | 1.103 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 7.881929e-02 | 1.103 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 7.881929e-02 | 1.103 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 7.881929e-02 | 1.103 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 7.881929e-02 | 1.103 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 7.881929e-02 | 1.103 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 7.881929e-02 | 1.103 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 7.881929e-02 | 1.103 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 7.881929e-02 | 1.103 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.950890e-02 | 1.100 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.972769e-02 | 1.098 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.084584e-02 | 1.092 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.084584e-02 | 1.092 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.329215e-02 | 1.079 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.342612e-02 | 1.079 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.342612e-02 | 1.079 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.342612e-02 | 1.079 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.457736e-02 | 1.073 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.457736e-02 | 1.073 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 8.793343e-02 | 1.056 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 8.793343e-02 | 1.056 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.136049e-01 | 0.945 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.136049e-01 | 0.945 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.136049e-01 | 0.945 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 9.300489e-02 | 1.031 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.668951e-02 | 1.015 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.037329e-01 | 0.984 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.037329e-01 | 0.984 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.042695e-01 | 0.982 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.749949e-02 | 1.058 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.554385e-02 | 1.068 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.841086e-02 | 1.007 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.073111e-01 | 0.969 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.029317e-01 | 0.987 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.818844e-02 | 1.008 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.133542e-01 | 0.946 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.037329e-01 | 0.984 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.621862e-02 | 1.017 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.136049e-01 | 0.945 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.621862e-02 | 1.017 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.678308e-02 | 1.062 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 9.668951e-02 | 1.015 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.615824e-02 | 1.017 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.468047e-02 | 1.024 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.017684e-01 | 0.992 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 8.793343e-02 | 1.056 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.136049e-01 | 0.945 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.095625e-01 | 0.960 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.749949e-02 | 1.058 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.127380e-01 | 0.948 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.176208e-02 | 1.037 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.136049e-01 | 0.945 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.014996e-02 | 1.045 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.096416e-01 | 0.960 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.102826e-01 | 0.957 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 8.793343e-02 | 1.056 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.136049e-01 | 0.945 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.059847e-01 | 0.975 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.918010e-02 | 1.004 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.096416e-01 | 0.960 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.083530e-01 | 0.965 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.037329e-01 | 0.984 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.037329e-01 | 0.984 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.668951e-02 | 1.015 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.446212e-02 | 1.025 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.554385e-02 | 1.068 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.136049e-01 | 0.945 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.139709e-01 | 0.943 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.147211e-01 | 0.940 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.149352e-01 | 0.940 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.176117e-01 | 0.930 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.197712e-01 | 0.922 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.231554e-01 | 0.910 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.231554e-01 | 0.910 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.231554e-01 | 0.910 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.231554e-01 | 0.910 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.249314e-01 | 0.903 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.249314e-01 | 0.903 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.262391e-01 | 0.899 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.262391e-01 | 0.899 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.272831e-01 | 0.895 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.273237e-01 | 0.895 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.273237e-01 | 0.895 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.273237e-01 | 0.895 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.273237e-01 | 0.895 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.281149e-01 | 0.892 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.309052e-01 | 0.883 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.338003e-01 | 0.874 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.374237e-01 | 0.862 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.374237e-01 | 0.862 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.374237e-01 | 0.862 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.380996e-01 | 0.860 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.382639e-01 | 0.859 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.382639e-01 | 0.859 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.382639e-01 | 0.859 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.408975e-01 | 0.851 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.408975e-01 | 0.851 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.408975e-01 | 0.851 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.408975e-01 | 0.851 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.408975e-01 | 0.851 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.408975e-01 | 0.851 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.417276e-01 | 0.849 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.425388e-01 | 0.846 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.428507e-01 | 0.845 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.447576e-01 | 0.839 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.459387e-01 | 0.836 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.459387e-01 | 0.836 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.459387e-01 | 0.836 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.461336e-01 | 0.835 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.469161e-01 | 0.833 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.489905e-01 | 0.827 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.500297e-01 | 0.824 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.506137e-01 | 0.822 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.507703e-01 | 0.822 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.507703e-01 | 0.822 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.514304e-01 | 0.820 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.514304e-01 | 0.820 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.514304e-01 | 0.820 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.514304e-01 | 0.820 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.514304e-01 | 0.820 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.514304e-01 | 0.820 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.514304e-01 | 0.820 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.514304e-01 | 0.820 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.514304e-01 | 0.820 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.514304e-01 | 0.820 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.515522e-01 | 0.819 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.523197e-01 | 0.817 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.543992e-01 | 0.811 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.551942e-01 | 0.809 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.573087e-01 | 0.803 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.183221e-01 | 0.661 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.183221e-01 | 0.661 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.183221e-01 | 0.661 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 2.183221e-01 | 0.661 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 2.183221e-01 | 0.661 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.693966e-01 | 0.771 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.987428e-01 | 0.702 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.987428e-01 | 0.702 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.062490e-01 | 0.686 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.062490e-01 | 0.686 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.062490e-01 | 0.686 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.274738e-01 | 0.643 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.002650e-01 | 0.698 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.909004e-01 | 0.719 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 2.344161e-01 | 0.630 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.344161e-01 | 0.630 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.195290e-01 | 0.659 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.343112e-01 | 0.630 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.343112e-01 | 0.630 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.801591e-01 | 0.744 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.312370e-01 | 0.636 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.640784e-01 | 0.785 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.386945e-01 | 0.622 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.251088e-01 | 0.648 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.251088e-01 | 0.648 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.980379e-01 | 0.703 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.608327e-01 | 0.794 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.291952e-01 | 0.640 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.054174e-01 | 0.687 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.684072e-01 | 0.774 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.062490e-01 | 0.686 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.344161e-01 | 0.630 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.966439e-01 | 0.706 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.286260e-01 | 0.641 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.062800e-01 | 0.686 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.062800e-01 | 0.686 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.929177e-01 | 0.715 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.733323e-01 | 0.761 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.688435e-01 | 0.773 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.653727e-01 | 0.782 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.771178e-01 | 0.752 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.109138e-01 | 0.676 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.387767e-01 | 0.622 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.014694e-01 | 0.696 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.092220e-01 | 0.679 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.183221e-01 | 0.661 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.909004e-01 | 0.719 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.807197e-01 | 0.743 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.929177e-01 | 0.715 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.267588e-01 | 0.644 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.267588e-01 | 0.644 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.855130e-01 | 0.732 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.195290e-01 | 0.659 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.294910e-01 | 0.639 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.274738e-01 | 0.643 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.361537e-01 | 0.627 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.108174e-01 | 0.676 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.693966e-01 | 0.771 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 2.286260e-01 | 0.641 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.062490e-01 | 0.686 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.601590e-01 | 0.795 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.286260e-01 | 0.641 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.253976e-01 | 0.647 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.878782e-01 | 0.726 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 1.855130e-01 | 0.732 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.195290e-01 | 0.659 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.152110e-01 | 0.667 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.719026e-01 | 0.765 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.693966e-01 | 0.771 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.987428e-01 | 0.702 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.161403e-01 | 0.665 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.790234e-01 | 0.747 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.407646e-01 | 0.618 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.413660e-01 | 0.617 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.799444e-01 | 0.553 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.367122e-01 | 0.473 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.367122e-01 | 0.473 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.367122e-01 | 0.473 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.587792e-01 | 0.587 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.587792e-01 | 0.587 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.587792e-01 | 0.587 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.587792e-01 | 0.587 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.890076e-01 | 0.410 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.890076e-01 | 0.410 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.890076e-01 | 0.410 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.890076e-01 | 0.410 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.890076e-01 | 0.410 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.371828e-01 | 0.359 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.371828e-01 | 0.359 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.371828e-01 | 0.359 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 4.371828e-01 | 0.359 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.371828e-01 | 0.359 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.371828e-01 | 0.359 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.709836e-01 | 0.567 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.709836e-01 | 0.567 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.487467e-01 | 0.457 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.930787e-01 | 0.533 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.930787e-01 | 0.533 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.780229e-01 | 0.422 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.780229e-01 | 0.422 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.780229e-01 | 0.422 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.815622e-01 | 0.317 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.815622e-01 | 0.317 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.815622e-01 | 0.317 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.815622e-01 | 0.317 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.815622e-01 | 0.317 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.493622e-01 | 0.603 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.493622e-01 | 0.603 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.493622e-01 | 0.603 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.493622e-01 | 0.603 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.375179e-01 | 0.472 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.375179e-01 | 0.472 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 3.375179e-01 | 0.472 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.060742e-01 | 0.514 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.060742e-01 | 0.514 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.067335e-01 | 0.391 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.597074e-01 | 0.444 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.716889e-01 | 0.566 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.716889e-01 | 0.566 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.427823e-01 | 0.465 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.427823e-01 | 0.465 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.347859e-01 | 0.362 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.347859e-01 | 0.362 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.347859e-01 | 0.362 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.275178e-01 | 0.485 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.611944e-01 | 0.442 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.611944e-01 | 0.442 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.611944e-01 | 0.442 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.036859e-01 | 0.394 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.435086e-01 | 0.464 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.583611e-01 | 0.588 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.621054e-01 | 0.335 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.621054e-01 | 0.335 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.138732e-01 | 0.503 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.138732e-01 | 0.503 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.253565e-01 | 0.371 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.979273e-01 | 0.400 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.709958e-01 | 0.431 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.679110e-01 | 0.434 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.522446e-01 | 0.345 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.395344e-01 | 0.357 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.553131e-01 | 0.342 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.367812e-01 | 0.360 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.583857e-01 | 0.339 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.482330e-01 | 0.348 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.843337e-01 | 0.315 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.321703e-01 | 0.364 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.435086e-01 | 0.464 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.709836e-01 | 0.567 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.964978e-01 | 0.528 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.427823e-01 | 0.465 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.435086e-01 | 0.464 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.801404e-01 | 0.553 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.435086e-01 | 0.464 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.580049e-01 | 0.588 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.606803e-01 | 0.443 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.243943e-01 | 0.489 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.621054e-01 | 0.335 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.490845e-01 | 0.604 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.889746e-01 | 0.539 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.646494e-01 | 0.577 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.275178e-01 | 0.485 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 2.493622e-01 | 0.603 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.306850e-01 | 0.366 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.698228e-01 | 0.569 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.161718e-01 | 0.381 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.114056e-01 | 0.507 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.587792e-01 | 0.587 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.890076e-01 | 0.410 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.487467e-01 | 0.457 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.979273e-01 | 0.400 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.376175e-01 | 0.472 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.979273e-01 | 0.400 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.886673e-01 | 0.540 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.493622e-01 | 0.603 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.855429e-01 | 0.544 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.102939e-01 | 0.387 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.882453e-01 | 0.540 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.371828e-01 | 0.359 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.371828e-01 | 0.359 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.371828e-01 | 0.359 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.780229e-01 | 0.422 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.375179e-01 | 0.472 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.595488e-01 | 0.444 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.916648e-01 | 0.407 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.304516e-01 | 0.481 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.522446e-01 | 0.345 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 2.519886e-01 | 0.599 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.698228e-01 | 0.569 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.189948e-01 | 0.378 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.698228e-01 | 0.569 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.890076e-01 | 0.410 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.890076e-01 | 0.410 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 4.371828e-01 | 0.359 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.855429e-01 | 0.544 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.036859e-01 | 0.394 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.138732e-01 | 0.503 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 4.467457e-01 | 0.350 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.582820e-01 | 0.588 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.342883e-01 | 0.362 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.707110e-01 | 0.327 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.465100e-01 | 0.608 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.597074e-01 | 0.444 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.243943e-01 | 0.489 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.076870e-01 | 0.390 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.382752e-01 | 0.471 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.756100e-01 | 0.425 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.471612e-01 | 0.459 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.621054e-01 | 0.335 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.972517e-01 | 0.527 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.471612e-01 | 0.459 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.930787e-01 | 0.533 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.004782e-01 | 0.397 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.979273e-01 | 0.400 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.275178e-01 | 0.485 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.776590e-01 | 0.556 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.799444e-01 | 0.553 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.799444e-01 | 0.553 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.890076e-01 | 0.410 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.890076e-01 | 0.410 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.190183e-01 | 0.496 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.371828e-01 | 0.359 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 4.815622e-01 | 0.317 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.815622e-01 | 0.317 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.815622e-01 | 0.317 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 4.815622e-01 | 0.317 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 4.815622e-01 | 0.317 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.060742e-01 | 0.514 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.243943e-01 | 0.489 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.621054e-01 | 0.335 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.395344e-01 | 0.357 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.698228e-01 | 0.569 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.093944e-01 | 0.509 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.275178e-01 | 0.485 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.102939e-01 | 0.387 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.583857e-01 | 0.339 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.047865e-01 | 0.516 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.225797e-01 | 0.491 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.601025e-01 | 0.337 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.709664e-01 | 0.327 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.700112e-01 | 0.328 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.530057e-01 | 0.452 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.161718e-01 | 0.381 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.236515e-01 | 0.373 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.395344e-01 | 0.357 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.511515e-01 | 0.346 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.765840e-01 | 0.322 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.578097e-01 | 0.339 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.595488e-01 | 0.444 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.756195e-01 | 0.560 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.709664e-01 | 0.327 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.890076e-01 | 0.410 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.371828e-01 | 0.359 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.815622e-01 | 0.317 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.493622e-01 | 0.603 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.565849e-01 | 0.448 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.161718e-01 | 0.381 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.735244e-01 | 0.428 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.949382e-01 | 0.403 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 2.889746e-01 | 0.539 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.060742e-01 | 0.514 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.756100e-01 | 0.425 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.726429e-01 | 0.429 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.460991e-01 | 0.461 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.661686e-01 | 0.436 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.661686e-01 | 0.436 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.597074e-01 | 0.444 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.678084e-01 | 0.330 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.069569e-01 | 0.513 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.367122e-01 | 0.473 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.367122e-01 | 0.473 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 2.587792e-01 | 0.587 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.587792e-01 | 0.587 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.487467e-01 | 0.457 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.487467e-01 | 0.457 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.930787e-01 | 0.533 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.597074e-01 | 0.444 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.435086e-01 | 0.464 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.795892e-01 | 0.421 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.522446e-01 | 0.345 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.522446e-01 | 0.345 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.314498e-01 | 0.365 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.713993e-01 | 0.327 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.070883e-01 | 0.513 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.375179e-01 | 0.472 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.279016e-01 | 0.484 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.605328e-01 | 0.584 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.286336e-01 | 0.368 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.875607e-01 | 0.312 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.979273e-01 | 0.400 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.279016e-01 | 0.484 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.036859e-01 | 0.394 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.321703e-01 | 0.364 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.709958e-01 | 0.431 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.843337e-01 | 0.315 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.161718e-01 | 0.381 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.367122e-01 | 0.473 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.889746e-01 | 0.539 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.487467e-01 | 0.457 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 4.815622e-01 | 0.317 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.375179e-01 | 0.472 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.257859e-01 | 0.487 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.700112e-01 | 0.328 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.875607e-01 | 0.312 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.875607e-01 | 0.312 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.583857e-01 | 0.339 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.660673e-01 | 0.436 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.142633e-01 | 0.383 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.865657e-01 | 0.413 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 4.347859e-01 | 0.362 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.864743e-01 | 0.313 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 4.621054e-01 | 0.335 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.979273e-01 | 0.400 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.537184e-01 | 0.596 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.383300e-01 | 0.358 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.587792e-01 | 0.587 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.587792e-01 | 0.587 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 4.371828e-01 | 0.359 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.815622e-01 | 0.317 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.347859e-01 | 0.362 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.253565e-01 | 0.371 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.161718e-01 | 0.381 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.678084e-01 | 0.330 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.023226e-01 | 0.395 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.889746e-01 | 0.539 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.487467e-01 | 0.457 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.815622e-01 | 0.317 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.817841e-01 | 0.418 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.253565e-01 | 0.371 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.735244e-01 | 0.428 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.435086e-01 | 0.464 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.371828e-01 | 0.359 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.371828e-01 | 0.359 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.979273e-01 | 0.400 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.597074e-01 | 0.444 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.332221e-01 | 0.477 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.498256e-01 | 0.602 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.885049e-01 | 0.311 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.886333e-01 | 0.311 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.886333e-01 | 0.311 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.886333e-01 | 0.311 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.886333e-01 | 0.311 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.886333e-01 | 0.311 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.886333e-01 | 0.311 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.886333e-01 | 0.311 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 4.886333e-01 | 0.311 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 4.886333e-01 | 0.311 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.946263e-01 | 0.306 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.946263e-01 | 0.306 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.953037e-01 | 0.305 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.018181e-01 | 0.299 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.018181e-01 | 0.299 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.048683e-01 | 0.297 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.108922e-01 | 0.292 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.131077e-01 | 0.290 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.143244e-01 | 0.289 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.143244e-01 | 0.289 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.143244e-01 | 0.289 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.143244e-01 | 0.289 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.143244e-01 | 0.289 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.143244e-01 | 0.289 | 0 | 0 |
| Translation | R-HSA-72766 | 5.190381e-01 | 0.285 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.219114e-01 | 0.282 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.219114e-01 | 0.282 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.223261e-01 | 0.282 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.224446e-01 | 0.282 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.224446e-01 | 0.282 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.224446e-01 | 0.282 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.224446e-01 | 0.282 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.224446e-01 | 0.282 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.224446e-01 | 0.282 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 5.224446e-01 | 0.282 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.224446e-01 | 0.282 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.224446e-01 | 0.282 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.224446e-01 | 0.282 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.224446e-01 | 0.282 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.224446e-01 | 0.282 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.226662e-01 | 0.282 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.237734e-01 | 0.281 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.312614e-01 | 0.275 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.319452e-01 | 0.274 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.350508e-01 | 0.272 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.373253e-01 | 0.270 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.374075e-01 | 0.270 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.386695e-01 | 0.269 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.391460e-01 | 0.268 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.391460e-01 | 0.268 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.391460e-01 | 0.268 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.391460e-01 | 0.268 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.423215e-01 | 0.266 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.465752e-01 | 0.262 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.466978e-01 | 0.262 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.480734e-01 | 0.261 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.480734e-01 | 0.261 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.480734e-01 | 0.261 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.489102e-01 | 0.260 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 5.551245e-01 | 0.256 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.551245e-01 | 0.256 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.551245e-01 | 0.256 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.596028e-01 | 0.252 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.596539e-01 | 0.252 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.601054e-01 | 0.252 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.601054e-01 | 0.252 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.601054e-01 | 0.252 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.601054e-01 | 0.252 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.601054e-01 | 0.252 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.601054e-01 | 0.252 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.601054e-01 | 0.252 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.601054e-01 | 0.252 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.601054e-01 | 0.252 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.601054e-01 | 0.252 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.601054e-01 | 0.252 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.601054e-01 | 0.252 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.601054e-01 | 0.252 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.630753e-01 | 0.249 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.630753e-01 | 0.249 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.630753e-01 | 0.249 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.649338e-01 | 0.248 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.651751e-01 | 0.248 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.670037e-01 | 0.246 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.670037e-01 | 0.246 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.712604e-01 | 0.243 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.712604e-01 | 0.243 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.712604e-01 | 0.243 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.712604e-01 | 0.243 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.836581e-01 | 0.234 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.854384e-01 | 0.233 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.854384e-01 | 0.233 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.860987e-01 | 0.232 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 5.860987e-01 | 0.232 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.860987e-01 | 0.232 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.860987e-01 | 0.232 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.860987e-01 | 0.232 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.860987e-01 | 0.232 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.870631e-01 | 0.231 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.947982e-01 | 0.226 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.947982e-01 | 0.226 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.947982e-01 | 0.226 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 5.947982e-01 | 0.226 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.947982e-01 | 0.226 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.947982e-01 | 0.226 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.947982e-01 | 0.226 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.947982e-01 | 0.226 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.947982e-01 | 0.226 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.947982e-01 | 0.226 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.947982e-01 | 0.226 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 5.947982e-01 | 0.226 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.947982e-01 | 0.226 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 5.947982e-01 | 0.226 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.947982e-01 | 0.226 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 5.947982e-01 | 0.226 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.947982e-01 | 0.226 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.947982e-01 | 0.226 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 5.947982e-01 | 0.226 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.949456e-01 | 0.226 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.015309e-01 | 0.221 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.016238e-01 | 0.221 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.025204e-01 | 0.220 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.033635e-01 | 0.219 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.033635e-01 | 0.219 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.082103e-01 | 0.216 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.082103e-01 | 0.216 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.082103e-01 | 0.216 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.082103e-01 | 0.216 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.082103e-01 | 0.216 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.082103e-01 | 0.216 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.176220e-01 | 0.209 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.207681e-01 | 0.207 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.207681e-01 | 0.207 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.207681e-01 | 0.207 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.207681e-01 | 0.207 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.215382e-01 | 0.207 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.267569e-01 | 0.203 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.267569e-01 | 0.203 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.267569e-01 | 0.203 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.267569e-01 | 0.203 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.267569e-01 | 0.203 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.267569e-01 | 0.203 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.267569e-01 | 0.203 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.267569e-01 | 0.203 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.294107e-01 | 0.201 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.294107e-01 | 0.201 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.294107e-01 | 0.201 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.294107e-01 | 0.201 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.294107e-01 | 0.201 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.304545e-01 | 0.200 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.323594e-01 | 0.199 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.323594e-01 | 0.199 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.323594e-01 | 0.199 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.323594e-01 | 0.199 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.323594e-01 | 0.199 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.323594e-01 | 0.199 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.323594e-01 | 0.199 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.376446e-01 | 0.195 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.407981e-01 | 0.193 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.414086e-01 | 0.193 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.430420e-01 | 0.192 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.452731e-01 | 0.190 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.467256e-01 | 0.189 | 1 | 1 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.497061e-01 | 0.187 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.497061e-01 | 0.187 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.497061e-01 | 0.187 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.497061e-01 | 0.187 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.509764e-01 | 0.186 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.539878e-01 | 0.184 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.557111e-01 | 0.183 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.557111e-01 | 0.183 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.557111e-01 | 0.183 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.557111e-01 | 0.183 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.557111e-01 | 0.183 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 6.557111e-01 | 0.183 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.561967e-01 | 0.183 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.561967e-01 | 0.183 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.561967e-01 | 0.183 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.561967e-01 | 0.183 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.561967e-01 | 0.183 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.561967e-01 | 0.183 | 0 | 0 |
| PAOs oxidise polyamines to amines | R-HSA-141334 | 6.561967e-01 | 0.183 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.561967e-01 | 0.183 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.561967e-01 | 0.183 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 6.561967e-01 | 0.183 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.561967e-01 | 0.183 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.561967e-01 | 0.183 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.561967e-01 | 0.183 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.609860e-01 | 0.180 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.643597e-01 | 0.178 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.643597e-01 | 0.178 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.680884e-01 | 0.175 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.680884e-01 | 0.175 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.680884e-01 | 0.175 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.691072e-01 | 0.175 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.691072e-01 | 0.175 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.691072e-01 | 0.175 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.693410e-01 | 0.174 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.697953e-01 | 0.174 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.755402e-01 | 0.170 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.833160e-01 | 0.165 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.833160e-01 | 0.165 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.833160e-01 | 0.165 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.833160e-01 | 0.165 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.833160e-01 | 0.165 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.833160e-01 | 0.165 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.833160e-01 | 0.165 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.833160e-01 | 0.165 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 6.833160e-01 | 0.165 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.833160e-01 | 0.165 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.833160e-01 | 0.165 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 6.833160e-01 | 0.165 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 6.833160e-01 | 0.165 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.833160e-01 | 0.165 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.833160e-01 | 0.165 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.850667e-01 | 0.164 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.864785e-01 | 0.163 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.875504e-01 | 0.163 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.876289e-01 | 0.163 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.876289e-01 | 0.163 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.876289e-01 | 0.163 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.876289e-01 | 0.163 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.919537e-01 | 0.160 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.971720e-01 | 0.157 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.992774e-01 | 0.155 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.998039e-01 | 0.155 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.003918e-01 | 0.155 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 7.027310e-01 | 0.153 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.034370e-01 | 0.153 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.052892e-01 | 0.152 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.052892e-01 | 0.152 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.052892e-01 | 0.152 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.052892e-01 | 0.152 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.076190e-01 | 0.150 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.082977e-01 | 0.150 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.082977e-01 | 0.150 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.082977e-01 | 0.150 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.082977e-01 | 0.150 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.082977e-01 | 0.150 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.082977e-01 | 0.150 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.082977e-01 | 0.150 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.082977e-01 | 0.150 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.128486e-01 | 0.147 | 1 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.128486e-01 | 0.147 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.140104e-01 | 0.146 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.140104e-01 | 0.146 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.146189e-01 | 0.146 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.173439e-01 | 0.144 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.221086e-01 | 0.141 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.221086e-01 | 0.141 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.221086e-01 | 0.141 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.221086e-01 | 0.141 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.249216e-01 | 0.140 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.276915e-01 | 0.138 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.313100e-01 | 0.136 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.313100e-01 | 0.136 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.313100e-01 | 0.136 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.313100e-01 | 0.136 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.313100e-01 | 0.136 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.313100e-01 | 0.136 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.313100e-01 | 0.136 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.313100e-01 | 0.136 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.313100e-01 | 0.136 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.313100e-01 | 0.136 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.313100e-01 | 0.136 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.313100e-01 | 0.136 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.313100e-01 | 0.136 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.313100e-01 | 0.136 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.313100e-01 | 0.136 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.313100e-01 | 0.136 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.313100e-01 | 0.136 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.313100e-01 | 0.136 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.313100e-01 | 0.136 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.376016e-01 | 0.132 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.376016e-01 | 0.132 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.381100e-01 | 0.132 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.381100e-01 | 0.132 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.381100e-01 | 0.132 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.381100e-01 | 0.132 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.381100e-01 | 0.132 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.381100e-01 | 0.132 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.408538e-01 | 0.130 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.408538e-01 | 0.130 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.408538e-01 | 0.130 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.408538e-01 | 0.130 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.408538e-01 | 0.130 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.408538e-01 | 0.130 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.420000e-01 | 0.130 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.430634e-01 | 0.129 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.445520e-01 | 0.128 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.469215e-01 | 0.127 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.471048e-01 | 0.127 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.479243e-01 | 0.126 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.525082e-01 | 0.123 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.525082e-01 | 0.123 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.525082e-01 | 0.123 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.525082e-01 | 0.123 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.525082e-01 | 0.123 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.525082e-01 | 0.123 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.525082e-01 | 0.123 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.525082e-01 | 0.123 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.525082e-01 | 0.123 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.525082e-01 | 0.123 | 0 | 0 |
| Interconversion of polyamines | R-HSA-351200 | 7.525082e-01 | 0.123 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.525082e-01 | 0.123 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.525082e-01 | 0.123 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.525082e-01 | 0.123 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.525082e-01 | 0.123 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.533176e-01 | 0.123 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.533176e-01 | 0.123 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.533176e-01 | 0.123 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.533176e-01 | 0.123 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.533176e-01 | 0.123 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.533176e-01 | 0.123 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.533176e-01 | 0.123 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.533176e-01 | 0.123 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.533176e-01 | 0.123 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.535051e-01 | 0.123 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.535051e-01 | 0.123 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.542780e-01 | 0.122 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.572810e-01 | 0.121 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.592830e-01 | 0.120 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.647222e-01 | 0.116 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.656545e-01 | 0.116 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.656545e-01 | 0.116 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.656545e-01 | 0.116 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.656545e-01 | 0.116 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.656545e-01 | 0.116 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.656545e-01 | 0.116 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.656545e-01 | 0.116 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.677571e-01 | 0.115 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.677571e-01 | 0.115 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.677571e-01 | 0.115 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.677571e-01 | 0.115 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.677571e-01 | 0.115 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.720351e-01 | 0.112 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.720351e-01 | 0.112 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.720351e-01 | 0.112 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.720351e-01 | 0.112 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.720351e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.720351e-01 | 0.112 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.720351e-01 | 0.112 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.720351e-01 | 0.112 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.720351e-01 | 0.112 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.720351e-01 | 0.112 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.720351e-01 | 0.112 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.720351e-01 | 0.112 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.764299e-01 | 0.110 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.773119e-01 | 0.109 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.774494e-01 | 0.109 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.814550e-01 | 0.107 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.814550e-01 | 0.107 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.814550e-01 | 0.107 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.816970e-01 | 0.107 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.822246e-01 | 0.107 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.822246e-01 | 0.107 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.884881e-01 | 0.103 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.884881e-01 | 0.103 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.884881e-01 | 0.103 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.900224e-01 | 0.102 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.900224e-01 | 0.102 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.900224e-01 | 0.102 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.900224e-01 | 0.102 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.900224e-01 | 0.102 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.900224e-01 | 0.102 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.900224e-01 | 0.102 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.900224e-01 | 0.102 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 7.900224e-01 | 0.102 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.900224e-01 | 0.102 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.904831e-01 | 0.102 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.916012e-01 | 0.101 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.933061e-01 | 0.101 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.944384e-01 | 0.100 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.944384e-01 | 0.100 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.944384e-01 | 0.100 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.991944e-01 | 0.097 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.056900e-01 | 0.094 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.065915e-01 | 0.093 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.065915e-01 | 0.093 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.065915e-01 | 0.093 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.065915e-01 | 0.093 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.065915e-01 | 0.093 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.065915e-01 | 0.093 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.065915e-01 | 0.093 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.065915e-01 | 0.093 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.065915e-01 | 0.093 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.065915e-01 | 0.093 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.065915e-01 | 0.093 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.067347e-01 | 0.093 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.067347e-01 | 0.093 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.067347e-01 | 0.093 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.080785e-01 | 0.093 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.080785e-01 | 0.093 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.094428e-01 | 0.092 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.094428e-01 | 0.092 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.105672e-01 | 0.091 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.168719e-01 | 0.088 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.168719e-01 | 0.088 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.180394e-01 | 0.087 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.182465e-01 | 0.087 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.183715e-01 | 0.087 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.183715e-01 | 0.087 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.192458e-01 | 0.087 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.192458e-01 | 0.087 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.192458e-01 | 0.087 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.210119e-01 | 0.086 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.218540e-01 | 0.085 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.218540e-01 | 0.085 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.218540e-01 | 0.085 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.218540e-01 | 0.085 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.218540e-01 | 0.085 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.218540e-01 | 0.085 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.218540e-01 | 0.085 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.253312e-01 | 0.083 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.253312e-01 | 0.083 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.334643e-01 | 0.079 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.359129e-01 | 0.078 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.359129e-01 | 0.078 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.359129e-01 | 0.078 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.359129e-01 | 0.078 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.359129e-01 | 0.078 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.359129e-01 | 0.078 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.359129e-01 | 0.078 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.359129e-01 | 0.078 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.375666e-01 | 0.077 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.375666e-01 | 0.077 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.375666e-01 | 0.077 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.377798e-01 | 0.077 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.377798e-01 | 0.077 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.382097e-01 | 0.077 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.397762e-01 | 0.076 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.397762e-01 | 0.076 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.397762e-01 | 0.076 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.412788e-01 | 0.075 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.413251e-01 | 0.075 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.415106e-01 | 0.075 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.418798e-01 | 0.075 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.461107e-01 | 0.073 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.472506e-01 | 0.072 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.481622e-01 | 0.072 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.487827e-01 | 0.071 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.488631e-01 | 0.071 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.488631e-01 | 0.071 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.488631e-01 | 0.071 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.488631e-01 | 0.071 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.488631e-01 | 0.071 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.488631e-01 | 0.071 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.488631e-01 | 0.071 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.488631e-01 | 0.071 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.495983e-01 | 0.071 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.495983e-01 | 0.071 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.495983e-01 | 0.071 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.495983e-01 | 0.071 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.495983e-01 | 0.071 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.495983e-01 | 0.071 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.495983e-01 | 0.071 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.495983e-01 | 0.071 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.495983e-01 | 0.071 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.525685e-01 | 0.069 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.540899e-01 | 0.068 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.542616e-01 | 0.068 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.588689e-01 | 0.066 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.588689e-01 | 0.066 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.588689e-01 | 0.066 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.607920e-01 | 0.065 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.607920e-01 | 0.065 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.607920e-01 | 0.065 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.607920e-01 | 0.065 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.607920e-01 | 0.065 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.607920e-01 | 0.065 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.607920e-01 | 0.065 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.607920e-01 | 0.065 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.607920e-01 | 0.065 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.607920e-01 | 0.065 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.607920e-01 | 0.065 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.607920e-01 | 0.065 | 0 | 0 |
| Amine Oxidase reactions | R-HSA-140179 | 8.607920e-01 | 0.065 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.607920e-01 | 0.065 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.607920e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.607920e-01 | 0.065 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.628920e-01 | 0.064 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.676138e-01 | 0.062 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.676138e-01 | 0.062 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.694373e-01 | 0.061 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.694373e-01 | 0.061 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.717800e-01 | 0.060 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.717800e-01 | 0.060 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.717800e-01 | 0.060 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.717800e-01 | 0.060 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.717800e-01 | 0.060 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.717800e-01 | 0.060 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.717800e-01 | 0.060 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.730767e-01 | 0.059 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.758583e-01 | 0.058 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.758583e-01 | 0.058 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.758583e-01 | 0.058 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.764886e-01 | 0.057 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.801707e-01 | 0.055 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.819013e-01 | 0.055 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.819013e-01 | 0.055 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.819013e-01 | 0.055 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.819013e-01 | 0.055 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.819013e-01 | 0.055 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.819789e-01 | 0.055 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.819789e-01 | 0.055 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.819789e-01 | 0.055 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.836268e-01 | 0.054 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.836268e-01 | 0.054 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.836268e-01 | 0.054 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.909431e-01 | 0.050 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.909431e-01 | 0.050 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.909431e-01 | 0.050 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.912242e-01 | 0.050 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 8.912242e-01 | 0.050 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.912242e-01 | 0.050 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.933148e-01 | 0.049 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.956540e-01 | 0.048 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.956540e-01 | 0.048 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.978301e-01 | 0.047 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.978301e-01 | 0.047 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.995221e-01 | 0.046 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.998116e-01 | 0.046 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.998116e-01 | 0.046 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.998116e-01 | 0.046 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.000501e-01 | 0.046 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.009246e-01 | 0.045 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.014222e-01 | 0.045 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.033350e-01 | 0.044 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.043100e-01 | 0.044 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.043100e-01 | 0.044 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.072223e-01 | 0.042 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.073855e-01 | 0.042 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.077216e-01 | 0.042 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.077216e-01 | 0.042 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.077216e-01 | 0.042 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.091473e-01 | 0.041 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.104042e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.104042e-01 | 0.041 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.121026e-01 | 0.040 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.121026e-01 | 0.040 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.124314e-01 | 0.040 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.150075e-01 | 0.039 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.150075e-01 | 0.039 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.150075e-01 | 0.039 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.150075e-01 | 0.039 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.150075e-01 | 0.039 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.161330e-01 | 0.038 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.188551e-01 | 0.037 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.188551e-01 | 0.037 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.208819e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.215163e-01 | 0.035 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.215163e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.217185e-01 | 0.035 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.217185e-01 | 0.035 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.217185e-01 | 0.035 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.217185e-01 | 0.035 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.217185e-01 | 0.035 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.217185e-01 | 0.035 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.217185e-01 | 0.035 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.217185e-01 | 0.035 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.224584e-01 | 0.035 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.258998e-01 | 0.033 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.261595e-01 | 0.033 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.261595e-01 | 0.033 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.261595e-01 | 0.033 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.267169e-01 | 0.033 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.278230e-01 | 0.033 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.279000e-01 | 0.032 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.279000e-01 | 0.032 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.279000e-01 | 0.032 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.279000e-01 | 0.032 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.279000e-01 | 0.032 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.279384e-01 | 0.032 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.287531e-01 | 0.032 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.287531e-01 | 0.032 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.293125e-01 | 0.032 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.310881e-01 | 0.031 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.313205e-01 | 0.031 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.334014e-01 | 0.030 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.334014e-01 | 0.030 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.335938e-01 | 0.030 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.335938e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.335938e-01 | 0.030 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.335938e-01 | 0.030 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.335938e-01 | 0.030 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.335938e-01 | 0.030 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.335938e-01 | 0.030 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.343519e-01 | 0.029 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.357767e-01 | 0.029 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.357767e-01 | 0.029 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.357767e-01 | 0.029 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.370783e-01 | 0.028 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.388382e-01 | 0.027 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.388382e-01 | 0.027 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.388382e-01 | 0.027 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.388382e-01 | 0.027 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.399578e-01 | 0.027 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.402083e-01 | 0.027 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.402986e-01 | 0.027 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.402986e-01 | 0.027 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.402986e-01 | 0.027 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.428783e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.428783e-01 | 0.026 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.436687e-01 | 0.025 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.436687e-01 | 0.025 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.436687e-01 | 0.025 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.436687e-01 | 0.025 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.436687e-01 | 0.025 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.436687e-01 | 0.025 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.436687e-01 | 0.025 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.481180e-01 | 0.023 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.481180e-01 | 0.023 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.481180e-01 | 0.023 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.481180e-01 | 0.023 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.481180e-01 | 0.023 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.492357e-01 | 0.023 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.505018e-01 | 0.022 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.510030e-01 | 0.022 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.512407e-01 | 0.022 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.522161e-01 | 0.021 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.522161e-01 | 0.021 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.542106e-01 | 0.020 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.542326e-01 | 0.020 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.559907e-01 | 0.020 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.559907e-01 | 0.020 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.571173e-01 | 0.019 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 9.594673e-01 | 0.018 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.594673e-01 | 0.018 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.594673e-01 | 0.018 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.621845e-01 | 0.017 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.626695e-01 | 0.017 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.626695e-01 | 0.017 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.626695e-01 | 0.017 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.652266e-01 | 0.015 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.656189e-01 | 0.015 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.656189e-01 | 0.015 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.656189e-01 | 0.015 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.656189e-01 | 0.015 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.656189e-01 | 0.015 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.672089e-01 | 0.014 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.675377e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.675498e-01 | 0.014 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.675498e-01 | 0.014 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.683355e-01 | 0.014 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.683355e-01 | 0.014 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.683355e-01 | 0.014 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.683355e-01 | 0.014 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.683355e-01 | 0.014 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.708375e-01 | 0.013 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.708375e-01 | 0.013 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.708375e-01 | 0.013 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.708375e-01 | 0.013 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.708375e-01 | 0.013 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.717559e-01 | 0.012 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.717559e-01 | 0.012 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.719502e-01 | 0.012 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.729212e-01 | 0.012 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.729212e-01 | 0.012 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.729212e-01 | 0.012 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.731420e-01 | 0.012 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.731420e-01 | 0.012 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.736566e-01 | 0.012 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.736566e-01 | 0.012 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.741833e-01 | 0.011 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.752645e-01 | 0.011 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.752645e-01 | 0.011 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.752673e-01 | 0.011 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.770272e-01 | 0.010 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.772193e-01 | 0.010 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.772193e-01 | 0.010 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.783000e-01 | 0.010 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.790198e-01 | 0.009 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.790198e-01 | 0.009 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.795291e-01 | 0.009 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.809044e-01 | 0.008 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.814496e-01 | 0.008 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.825166e-01 | 0.008 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.836121e-01 | 0.007 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.836121e-01 | 0.007 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.836121e-01 | 0.007 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.836121e-01 | 0.007 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.836121e-01 | 0.007 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.841327e-01 | 0.007 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.849076e-01 | 0.007 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.849076e-01 | 0.007 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.851182e-01 | 0.007 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.856331e-01 | 0.006 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.861008e-01 | 0.006 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.861008e-01 | 0.006 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.861008e-01 | 0.006 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.861008e-01 | 0.006 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.861008e-01 | 0.006 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.868628e-01 | 0.006 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.874924e-01 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.878804e-01 | 0.005 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.878804e-01 | 0.005 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.883391e-01 | 0.005 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.886941e-01 | 0.005 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.887156e-01 | 0.005 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.887156e-01 | 0.005 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.894947e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.899062e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.900025e-01 | 0.004 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.902211e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.905438e-01 | 0.004 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.907931e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.914200e-01 | 0.004 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.915213e-01 | 0.004 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.921919e-01 | 0.003 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.926668e-01 | 0.003 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.927270e-01 | 0.003 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.927270e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.931778e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.931778e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.935524e-01 | 0.003 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.936271e-01 | 0.003 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.939021e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.940357e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.942280e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.943845e-01 | 0.002 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.947100e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.948288e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.952379e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.952379e-01 | 0.002 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.958336e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.959617e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.962813e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.962813e-01 | 0.002 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.965475e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.965514e-01 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.965514e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.965756e-01 | 0.001 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.965756e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.969150e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.970962e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.973338e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.973570e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.975337e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.979122e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.980255e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.980775e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.980775e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.981722e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.981976e-01 | 0.001 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.983699e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.984358e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.984358e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.984989e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.984989e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.985364e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.986178e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.987384e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.988281e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.989058e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.991112e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.991309e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.991576e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.991583e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.992531e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.992777e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.993473e-01 | 0.000 | 1 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.994647e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.994856e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.994866e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.995895e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.997186e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997186e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.997186e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.997813e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997931e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998513e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998781e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999071e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999257e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.999356e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999436e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999604e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999613e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999721e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999870e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999876e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999878e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999900e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.999903e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999930e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999946e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999970e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999978e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999985e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999990e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999996e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999998e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |